[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fyCUuFxxEuEfN4BqJq6g8uUtAPJ-lh69ch_HY2HkpPxk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":33,"phaseBuckets":84,"rows":91},"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",[4],126,false,18,13,13510,30,[13,16,19,22,25,27,29,31],{"name":14,"count":15},"Chronic Arsenic Poisoning",7,{"name":17,"count":18},"Keratotic Nodular Size",6,{"name":20,"count":21},"Arsenical Keratosis",4,{"name":23,"count":24},"Covid19",3,{"name":26,"count":24},"Parkinson Disease",{"name":28,"count":24},"MDD",{"name":30,"count":24},"Rheumatoid Arthritis",{"name":32,"count":24},"OCD",[34,39,44,49,54,59,64,69,74,79],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06570980","Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.","2024-08-30","sulfonylurease with metformin, DPP4 inhibitors with Metformin",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06936215","Safety and Efficacy of Baricitinib on Skin Tightening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate","2025-05","tab baricitinib 4 mg daily",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07055958","Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients","2025-06-30","Metformin",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT07036952","Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.","2025-10-30","Omega 3 fatty acids",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06896981","Semaglutide in Women With Polycystic Ovary Syndrome and Obesity","2025-10-31","Metformin with Semaglutide",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT05680805","Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS","2025-11-30","Metformin Hydrochloride",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT07185802","Clinical Outcome of Intra Articular Injection of Autologous Platelet Rich Plasma in Anterior Cruciate Ligament Injury.","2026-04","PRP",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT07161336","Role of Methotrexate in Ultrasound Proven Synovitis in Primary Knee OA","2026-07-01","Methotrexate",{"nctId":75,"briefTitle":76,"date":77,"intervention":78},"NCT07537634","Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication","2026-08-14","vonoprazan-based triple therapy",{"nctId":80,"briefTitle":81,"date":82,"intervention":83},"NCT07008846","Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis","2026-09-30","To see the efficacy of Upadacitinib, Methotrexate versus Tofacitinib, Methotrexate in moderate to severe Rheumatoid arthritis",[85,86,87,88,89,90],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[92,121,139,161,183,201,222,243,265,301,325,343,365,386,425,467,489,525,562,596,621,639,665,683,706,733,751,779,797,815,833,851,875,900,918,945,963,981,999,1025,1043,1068,1086,1104,1122,1147,1171,1189,1216,1234,1261,1279,1305,1330,1356,1374,1403,1421,1439,1457,1480,1506,1524,1550,1574,1598,1623,1648,1666,1684,1710,1728,1752,1777,1800,1822,1845,1871,1893,1918,1942,1967,1991,2014,2037,2061,2079,2105,2129,2147,2172,2195,2222,2240,2258,2282,2307,2325,2350,2375,2393,2416,2439,2462,2487,2505,2523,2547,2570,2597,2615,2638,2663,2718,2746,2779,2803,2827,2851,2874,2898,2925,2943,2961,2985,3003,3030,3052],{"intervention":78,"totalTrials":93,"cells":94},1,{"EARLY_PHASE1":95,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":119},{"trials":96,"activeCount":97},[],0,{"trials":99,"activeCount":97},[],{"trials":101,"activeCount":97},[],{"trials":103,"activeCount":97},[],{"trials":105,"activeCount":93,"soonestReadout":77},[106],{"nctId":75,"briefTitle":76,"status":107,"phases":108,"primaryCompletion":77,"completion":77,"start":109,"enrollment":110,"conditions":111,"interventions":117},"RECRUITING",[89],"2026-04-15",80,[112,113,114,115,116],"Helicobacter Pylori Infection","Dyspepsia","Peptic Ulcer Disease","Helicobacter Pylori","H Pylori",[78,118],"Esomeprazole-based triple therapy",{"trials":120,"activeCount":97},[],{"intervention":118,"totalTrials":93,"cells":122},{"EARLY_PHASE1":123,"PHASE1":125,"PHASE2":127,"PHASE3":129,"PHASE4":131,"NA":137},{"trials":124,"activeCount":97},[],{"trials":126,"activeCount":97},[],{"trials":128,"activeCount":97},[],{"trials":130,"activeCount":97},[],{"trials":132,"activeCount":93,"soonestReadout":77},[133],{"nctId":75,"briefTitle":76,"status":107,"phases":134,"primaryCompletion":77,"completion":77,"start":109,"enrollment":110,"conditions":135,"interventions":136},[89],[112,113,114,115,116],[78,118],{"trials":138,"activeCount":97},[],{"intervention":63,"totalTrials":93,"cells":140},{"EARLY_PHASE1":141,"PHASE1":143,"PHASE2":145,"PHASE3":147,"PHASE4":149,"NA":159},{"trials":142,"activeCount":97},[],{"trials":144,"activeCount":97},[],{"trials":146,"activeCount":97},[],{"trials":148,"activeCount":97},[],{"trials":150,"activeCount":93,"soonestReadout":62},[151],{"nctId":60,"briefTitle":61,"status":152,"phases":153,"primaryCompletion":62,"completion":62,"start":154,"enrollment":155,"conditions":156,"interventions":158},"ACTIVE_NOT_RECRUITING",[89],"2023-05-27",100,[157,48],"Polycystic Ovary Syndrome",[63],{"trials":160,"activeCount":97},[],{"intervention":43,"totalTrials":93,"cells":162},{"EARLY_PHASE1":163,"PHASE1":165,"PHASE2":167,"PHASE3":169,"PHASE4":179,"NA":181},{"trials":164,"activeCount":97},[],{"trials":166,"activeCount":97},[],{"trials":168,"activeCount":97},[],{"trials":170,"activeCount":93,"soonestReadout":42},[171],{"nctId":40,"briefTitle":41,"status":107,"phases":172,"primaryCompletion":42,"completion":42,"start":173,"enrollment":174,"conditions":175,"interventions":177},[88],"2024-01-01",24,[176],"Diffuse Cutaneous Systemic Sclerosis",[43,178],"tab methotrexate 25 mg weekly with folic acid 5 mg weekly",{"trials":180,"activeCount":97},[],{"trials":182,"activeCount":97},[],{"intervention":178,"totalTrials":93,"cells":184},{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":197,"NA":199},{"trials":186,"activeCount":97},[],{"trials":188,"activeCount":97},[],{"trials":190,"activeCount":97},[],{"trials":192,"activeCount":93,"soonestReadout":42},[193],{"nctId":40,"briefTitle":41,"status":107,"phases":194,"primaryCompletion":42,"completion":42,"start":173,"enrollment":174,"conditions":195,"interventions":196},[88],[176],[43,178],{"trials":198,"activeCount":97},[],{"trials":200,"activeCount":97},[],{"intervention":83,"totalTrials":93,"cells":202},{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":218,"NA":220},{"trials":204,"activeCount":97},[],{"trials":206,"activeCount":97},[],{"trials":208,"activeCount":97},[],{"trials":210,"activeCount":93,"soonestReadout":82},[211],{"nctId":80,"briefTitle":81,"status":152,"phases":212,"primaryCompletion":82,"completion":82,"start":213,"enrollment":214,"conditions":215,"interventions":217},[88],"2025-05-10",96,[216],"Moderate to Severe Rheumatoid Arthritis",[83],{"trials":219,"activeCount":97},[],{"trials":221,"activeCount":97},[],{"intervention":48,"totalTrials":93,"cells":223},{"EARLY_PHASE1":224,"PHASE1":226,"PHASE2":228,"PHASE3":230,"PHASE4":239,"NA":241},{"trials":225,"activeCount":97},[],{"trials":227,"activeCount":97},[],{"trials":229,"activeCount":97},[],{"trials":231,"activeCount":93,"soonestReadout":47},[232],{"nctId":45,"briefTitle":46,"status":152,"phases":233,"primaryCompletion":47,"completion":234,"start":235,"enrollment":236,"conditions":237,"interventions":238},[88],"2025-07-20","2024-12-29",74,[26],[48],{"trials":240,"activeCount":97},[],{"trials":242,"activeCount":97},[],{"intervention":58,"totalTrials":93,"cells":244},{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":251,"PHASE4":261,"NA":263},{"trials":246,"activeCount":97},[],{"trials":248,"activeCount":97},[],{"trials":250,"activeCount":97},[],{"trials":252,"activeCount":93,"soonestReadout":57},[253],{"nctId":55,"briefTitle":56,"status":107,"phases":254,"primaryCompletion":57,"completion":255,"start":256,"enrollment":11,"conditions":257,"interventions":260},[87,88],"2025-12-31","2025-02-01",[258,259],"Polycystic Ovary Syndrome (PCOS) Women","Obesity",[58],{"trials":262,"activeCount":97},[],{"trials":264,"activeCount":97},[],{"intervention":73,"totalTrials":266,"cells":267},2,{"EARLY_PHASE1":268,"PHASE1":270,"PHASE2":272,"PHASE3":283,"PHASE4":285,"NA":299},{"trials":269,"activeCount":97},[],{"trials":271,"activeCount":97},[],{"trials":273,"activeCount":93,"soonestReadout":72},[274],{"nctId":70,"briefTitle":71,"status":107,"phases":275,"primaryCompletion":72,"completion":276,"start":277,"enrollment":278,"conditions":279,"interventions":282},[87],"2026-08-30","2025-07-30",70,[280,281,73],"Osteo Arthritis of the Knee","Synovitis of Knee",[73],{"trials":284,"activeCount":97},[],{"trials":286,"activeCount":97},[287],{"nctId":288,"briefTitle":289,"status":290,"phases":291,"primaryCompletion":292,"completion":292,"start":293,"enrollment":294,"conditions":295,"interventions":297},"NCT07472166","Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate","COMPLETED",[89],"2025-08-30","2024-12-21",34,[296],"Scleroderma, Systemic",[298,73],"Tofacitinib",{"trials":300,"activeCount":97},[],{"intervention":53,"totalTrials":93,"cells":302},{"EARLY_PHASE1":303,"PHASE1":305,"PHASE2":307,"PHASE3":309,"PHASE4":311,"NA":313},{"trials":304,"activeCount":97},[],{"trials":306,"activeCount":97},[],{"trials":308,"activeCount":97},[],{"trials":310,"activeCount":97},[],{"trials":312,"activeCount":97},[],{"trials":314,"activeCount":93,"soonestReadout":52},[315],{"nctId":50,"briefTitle":51,"status":316,"phases":317,"primaryCompletion":52,"completion":318,"start":319,"enrollment":320,"conditions":321,"interventions":323},"ENROLLING_BY_INVITATION",[90],"2025-12-30","2025-04-22",68,[322],"PCOS (Polycystic Ovary Syndrome)",[53,324],"Omega -3 fatty acids",{"intervention":324,"totalTrials":93,"cells":326},{"EARLY_PHASE1":327,"PHASE1":329,"PHASE2":331,"PHASE3":333,"PHASE4":335,"NA":337},{"trials":328,"activeCount":97},[],{"trials":330,"activeCount":97},[],{"trials":332,"activeCount":97},[],{"trials":334,"activeCount":97},[],{"trials":336,"activeCount":97},[],{"trials":338,"activeCount":93,"soonestReadout":52},[339],{"nctId":50,"briefTitle":51,"status":316,"phases":340,"primaryCompletion":52,"completion":318,"start":319,"enrollment":320,"conditions":341,"interventions":342},[90],[322],[53,324],{"intervention":68,"totalTrials":93,"cells":344},{"EARLY_PHASE1":345,"PHASE1":347,"PHASE2":349,"PHASE3":351,"PHASE4":353,"NA":355},{"trials":346,"activeCount":97},[],{"trials":348,"activeCount":97},[],{"trials":350,"activeCount":97},[],{"trials":352,"activeCount":97},[],{"trials":354,"activeCount":97},[],{"trials":356,"activeCount":93,"soonestReadout":67},[357],{"nctId":65,"briefTitle":66,"status":107,"phases":358,"primaryCompletion":67,"completion":359,"start":360,"enrollment":361,"conditions":362,"interventions":364},[90],"2026-08-26","2025-08-27",52,[363],"Anterior Cruciate Ligament",[68],{"intervention":38,"totalTrials":93,"cells":366},{"EARLY_PHASE1":367,"PHASE1":369,"PHASE2":371,"PHASE3":373,"PHASE4":375,"NA":377},{"trials":368,"activeCount":97},[],{"trials":370,"activeCount":97},[],{"trials":372,"activeCount":97},[],{"trials":374,"activeCount":97},[],{"trials":376,"activeCount":97},[],{"trials":378,"activeCount":93,"soonestReadout":37},[379],{"nctId":35,"briefTitle":36,"status":107,"phases":380,"primaryCompletion":37,"completion":37,"start":381,"enrollment":382,"conditions":383,"interventions":385},[],"2023-08-25",200,[384],"Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin",[38],{"intervention":298,"totalTrials":24,"cells":387},{"EARLY_PHASE1":388,"PHASE1":390,"PHASE2":392,"PHASE3":405,"PHASE4":407,"NA":423},{"trials":389,"activeCount":97},[],{"trials":391,"activeCount":97},[],{"trials":393,"activeCount":97},[394],{"nctId":395,"briefTitle":396,"status":397,"phases":398,"primaryCompletion":399,"completion":399,"start":400,"enrollment":401,"conditions":402,"interventions":404},"NCT06044844","Effectiveness of Tofacitinib in Systemic Sclerosis","UNKNOWN",[87],"2024-05","2023-11",44,[403],"Efficacy of Tofacitinib in the Systemic Sclerosis",[298],{"trials":406,"activeCount":97},[],{"trials":408,"activeCount":97},[409,413],{"nctId":288,"briefTitle":289,"status":290,"phases":410,"primaryCompletion":292,"completion":292,"start":293,"enrollment":294,"conditions":411,"interventions":412},[89],[296],[298,73],{"nctId":414,"briefTitle":415,"status":290,"phases":416,"primaryCompletion":417,"completion":417,"start":418,"enrollment":419,"conditions":420,"interventions":422},"NCT06310057","Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study",[89],"2024-03-01","2022-01-01",92,[421],"Axial Spondyloarthritis",[298],{"trials":424,"activeCount":97},[],{"intervention":426,"totalTrials":266,"cells":427},"Paclitaxel",{"EARLY_PHASE1":428,"PHASE1":430,"PHASE2":432,"PHASE3":448,"PHASE4":450,"NA":465},{"trials":429,"activeCount":97},[],{"trials":431,"activeCount":97},[],{"trials":433,"activeCount":97},[434],{"nctId":435,"briefTitle":436,"status":397,"phases":437,"primaryCompletion":438,"completion":439,"start":440,"enrollment":441,"conditions":442,"interventions":444},"NCT05872412","Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer",[87],"2024-03-31","2024-04-30","2023-06-01",82,[443],"Triple Negative Breast Cancer",[445,446,426,447],"Doxorubicin","Cyclophosphamide","Carboplatin",{"trials":449,"activeCount":97},[],{"trials":451,"activeCount":97},[452],{"nctId":453,"briefTitle":454,"status":290,"phases":455,"primaryCompletion":456,"completion":457,"start":458,"enrollment":459,"conditions":460,"interventions":462},"NCT03092986","Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer",[89],"2018-06-01","2018-12","2017-01-01",60,[461],"Carcinoma, Non-Small-Cell Lung",[426,447,463,464],"Cisplatin","Vinblastine Sulfate",{"trials":466,"activeCount":97},[],{"intervention":447,"totalTrials":266,"cells":468},{"EARLY_PHASE1":469,"PHASE1":471,"PHASE2":473,"PHASE3":479,"PHASE4":481,"NA":487},{"trials":470,"activeCount":97},[],{"trials":472,"activeCount":97},[],{"trials":474,"activeCount":97},[475],{"nctId":435,"briefTitle":436,"status":397,"phases":476,"primaryCompletion":438,"completion":439,"start":440,"enrollment":441,"conditions":477,"interventions":478},[87],[443],[445,446,426,447],{"trials":480,"activeCount":97},[],{"trials":482,"activeCount":97},[483],{"nctId":453,"briefTitle":454,"status":290,"phases":484,"primaryCompletion":456,"completion":457,"start":458,"enrollment":459,"conditions":485,"interventions":486},[89],[461],[426,447,463,464],{"trials":488,"activeCount":97},[],{"intervention":490,"totalTrials":266,"cells":491},"Thalidomide",{"EARLY_PHASE1":492,"PHASE1":494,"PHASE2":505,"PHASE3":507,"PHASE4":509,"NA":523},{"trials":493,"activeCount":97},[],{"trials":495,"activeCount":97},[496],{"nctId":497,"briefTitle":498,"status":290,"phases":499,"primaryCompletion":500,"completion":500,"start":501,"enrollment":459,"conditions":502,"interventions":504},"NCT06098014","Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia",[86],"2024-02-28","2023-03-01",[503],"Transfusion-dependent Thalassemia",[490],{"trials":506,"activeCount":97},[],{"trials":508,"activeCount":97},[],{"trials":510,"activeCount":97},[511],{"nctId":512,"briefTitle":513,"status":397,"phases":514,"primaryCompletion":515,"completion":516,"start":517,"enrollment":518,"conditions":519,"interventions":520},"NCT06299670","Efficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Treatment of Transfusion Dependent Thalassemia in Children: A Quasi-Randomised Clinical Trial",[89],"2024-06-30","2024-12-31","2023-11-01",90,[503],[490,521,522],"Hydroxy Urea","Combinations",{"trials":524,"activeCount":97},[],{"intervention":526,"totalTrials":266,"cells":527},"Prucalopride 2mg",{"EARLY_PHASE1":528,"PHASE1":530,"PHASE2":532,"PHASE3":534,"PHASE4":547,"NA":560},{"trials":529,"activeCount":97},[],{"trials":531,"activeCount":97},[],{"trials":533,"activeCount":97},[],{"trials":535,"activeCount":97},[536],{"nctId":537,"briefTitle":538,"status":397,"phases":539,"primaryCompletion":540,"completion":541,"start":542,"enrollment":543,"conditions":544,"interventions":546},"NCT04757493","The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome",[87,88],"2021-10-20","2021-11-20","2021-03-10",160,[545],"Irritable Bowel Syndrome",[526],{"trials":548,"activeCount":97},[549],{"nctId":550,"briefTitle":551,"status":397,"phases":552,"primaryCompletion":553,"completion":554,"start":555,"enrollment":556,"conditions":557,"interventions":559},"NCT04985669","Study of Comparative Effectiveness of Prucalopride and Lubiprostone in Constipation Predominant Irritable Bowel Syndrome",[89],"2022-02","2022-03","2021-08-15",140,[558],"Patient Satisfaction",[526],{"trials":561,"activeCount":97},[],{"intervention":563,"totalTrials":266,"cells":564},"Baricitinib 2 MG",{"EARLY_PHASE1":565,"PHASE1":567,"PHASE2":569,"PHASE3":571,"PHASE4":573,"NA":594},{"trials":566,"activeCount":97},[],{"trials":568,"activeCount":97},[],{"trials":570,"activeCount":97},[],{"trials":572,"activeCount":97},[],{"trials":574,"activeCount":97},[575,584],{"nctId":576,"briefTitle":577,"status":397,"phases":578,"primaryCompletion":438,"completion":438,"start":579,"enrollment":580,"conditions":581,"interventions":582},"NCT05827497","Baricitinib, Methotrexate as Monotherapy or Combination in the Treatment of Rheumatoid Arthritis - an Open Label Randomized Clinical Trial",[89],"2023-04-01",132,[30],[563,583],"Methotrexate 25mg",{"nctId":585,"briefTitle":586,"status":290,"phases":587,"primaryCompletion":588,"completion":588,"start":589,"enrollment":590,"conditions":591,"interventions":592},"NCT05660655","Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis",[89],"2023-09-30","2022-10-01",94,[30],[593,563],"Baricitinib 4 MG Oral",{"trials":595,"activeCount":97},[],{"intervention":597,"totalTrials":93,"cells":598},"Mirabegron 25mg",{"EARLY_PHASE1":599,"PHASE1":601,"PHASE2":603,"PHASE3":605,"PHASE4":607,"NA":619},{"trials":600,"activeCount":97},[],{"trials":602,"activeCount":97},[],{"trials":604,"activeCount":97},[],{"trials":606,"activeCount":97},[],{"trials":608,"activeCount":97},[609],{"nctId":610,"briefTitle":611,"status":290,"phases":612,"primaryCompletion":613,"completion":613,"start":458,"enrollment":614,"conditions":615,"interventions":617},"NCT03558919","Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder",[89],"2017-12-30",81,[616],"Overactive Bladder",[597,618],"Solifenacin Succinate 5 MG",{"trials":620,"activeCount":97},[],{"intervention":618,"totalTrials":93,"cells":622},{"EARLY_PHASE1":623,"PHASE1":625,"PHASE2":627,"PHASE3":629,"PHASE4":631,"NA":637},{"trials":624,"activeCount":97},[],{"trials":626,"activeCount":97},[],{"trials":628,"activeCount":97},[],{"trials":630,"activeCount":97},[],{"trials":632,"activeCount":97},[633],{"nctId":610,"briefTitle":611,"status":290,"phases":634,"primaryCompletion":613,"completion":613,"start":458,"enrollment":614,"conditions":635,"interventions":636},[89],[616],[597,618],{"trials":638,"activeCount":97},[],{"intervention":640,"totalTrials":93,"cells":641},"Cisplatin 40 mg\u002Fm2",{"EARLY_PHASE1":642,"PHASE1":644,"PHASE2":646,"PHASE3":648,"PHASE4":650,"NA":663},{"trials":643,"activeCount":97},[],{"trials":645,"activeCount":97},[],{"trials":647,"activeCount":97},[],{"trials":649,"activeCount":97},[],{"trials":651,"activeCount":97},[652],{"nctId":653,"briefTitle":654,"status":290,"phases":655,"primaryCompletion":656,"completion":657,"start":658,"enrollment":459,"conditions":659,"interventions":661},"NCT03998696","An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.",[89],"2018-06-30","2018-12-31","2017-07-01",[660],"Head and Neck Squamous Cell Carcinoma",[640,662],"Cisplatin 100 mg\u002Fm2",{"trials":664,"activeCount":97},[],{"intervention":662,"totalTrials":93,"cells":666},{"EARLY_PHASE1":667,"PHASE1":669,"PHASE2":671,"PHASE3":673,"PHASE4":675,"NA":681},{"trials":668,"activeCount":97},[],{"trials":670,"activeCount":97},[],{"trials":672,"activeCount":97},[],{"trials":674,"activeCount":97},[],{"trials":676,"activeCount":97},[677],{"nctId":653,"briefTitle":654,"status":290,"phases":678,"primaryCompletion":656,"completion":657,"start":658,"enrollment":459,"conditions":679,"interventions":680},[89],[660],[640,662],{"trials":682,"activeCount":97},[],{"intervention":684,"totalTrials":93,"cells":685},"Paracetamol",{"EARLY_PHASE1":686,"PHASE1":688,"PHASE2":690,"PHASE3":692,"PHASE4":694,"NA":704},{"trials":687,"activeCount":97},[],{"trials":689,"activeCount":97},[],{"trials":691,"activeCount":97},[],{"trials":693,"activeCount":97},[],{"trials":695,"activeCount":97},[696],{"nctId":697,"briefTitle":698,"status":397,"phases":699,"primaryCompletion":700,"completion":700,"start":540,"enrollment":459,"conditions":701,"interventions":703},"NCT05354479","Breastmilk Alone or in Combination With Paracetamol for Reducing Pain",[89],"2022-04-19",[702],"Pain Control",[684],{"trials":705,"activeCount":97},[],{"intervention":707,"totalTrials":93,"cells":708},"Tablet Nitrofurantoin",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":717,"NA":731},{"trials":710,"activeCount":97},[],{"trials":712,"activeCount":97},[],{"trials":714,"activeCount":97},[],{"trials":716,"activeCount":97},[],{"trials":718,"activeCount":97},[719],{"nctId":720,"briefTitle":721,"status":290,"phases":722,"primaryCompletion":657,"completion":723,"start":724,"enrollment":725,"conditions":726,"interventions":729},"NCT03716804","Establish the Relationship Between Shift in Prescribing Pattern and Associated Shift in Sensitivity Pattern of Causative Microbes in UTI Patients in a Closed Community",[89],"2019-01-31","2018-06-06",62,[727,728],"Uncomplicated Urinary Tract Infection","Antibiotic Resistant Infection",[707,730],"Tablet Ciprofloxacin\u002F Tablet Cefixime\u002F Tablet Cefuroxime",{"trials":732,"activeCount":97},[],{"intervention":730,"totalTrials":93,"cells":734},{"EARLY_PHASE1":735,"PHASE1":737,"PHASE2":739,"PHASE3":741,"PHASE4":743,"NA":749},{"trials":736,"activeCount":97},[],{"trials":738,"activeCount":97},[],{"trials":740,"activeCount":97},[],{"trials":742,"activeCount":97},[],{"trials":744,"activeCount":97},[745],{"nctId":720,"briefTitle":721,"status":290,"phases":746,"primaryCompletion":657,"completion":723,"start":724,"enrollment":725,"conditions":747,"interventions":748},[89],[727,728],[707,730],{"trials":750,"activeCount":97},[],{"intervention":752,"totalTrials":93,"cells":753},"Injection Mecobalamin,",{"EARLY_PHASE1":754,"PHASE1":756,"PHASE2":758,"PHASE3":760,"PHASE4":762,"NA":777},{"trials":755,"activeCount":97},[],{"trials":757,"activeCount":97},[],{"trials":759,"activeCount":97},[],{"trials":761,"activeCount":97},[],{"trials":763,"activeCount":97},[764],{"nctId":765,"briefTitle":766,"status":290,"phases":767,"primaryCompletion":768,"completion":769,"start":770,"enrollment":771,"conditions":772,"interventions":774},"NCT02923388","Neuroprotective Effect of Vitamin B12 and Vitamin B6 Against Vincristine Induced Peripheral Neuropathy",[89],"2018-06","2018-07","2016-10",88,[773],"Vincristine Induced Peripheral Neuropathy (VIPN)",[752,775,776],"Tablet Pyridoxine hydrochloride","Intravenous normal saline 1 ml",{"trials":778,"activeCount":97},[],{"intervention":775,"totalTrials":93,"cells":780},{"EARLY_PHASE1":781,"PHASE1":783,"PHASE2":785,"PHASE3":787,"PHASE4":789,"NA":795},{"trials":782,"activeCount":97},[],{"trials":784,"activeCount":97},[],{"trials":786,"activeCount":97},[],{"trials":788,"activeCount":97},[],{"trials":790,"activeCount":97},[791],{"nctId":765,"briefTitle":766,"status":290,"phases":792,"primaryCompletion":768,"completion":769,"start":770,"enrollment":771,"conditions":793,"interventions":794},[89],[773],[752,775,776],{"trials":796,"activeCount":97},[],{"intervention":776,"totalTrials":93,"cells":798},{"EARLY_PHASE1":799,"PHASE1":801,"PHASE2":803,"PHASE3":805,"PHASE4":807,"NA":813},{"trials":800,"activeCount":97},[],{"trials":802,"activeCount":97},[],{"trials":804,"activeCount":97},[],{"trials":806,"activeCount":97},[],{"trials":808,"activeCount":97},[809],{"nctId":765,"briefTitle":766,"status":290,"phases":810,"primaryCompletion":768,"completion":769,"start":770,"enrollment":771,"conditions":811,"interventions":812},[89],[773],[752,775,776],{"trials":814,"activeCount":97},[],{"intervention":463,"totalTrials":93,"cells":816},{"EARLY_PHASE1":817,"PHASE1":819,"PHASE2":821,"PHASE3":823,"PHASE4":825,"NA":831},{"trials":818,"activeCount":97},[],{"trials":820,"activeCount":97},[],{"trials":822,"activeCount":97},[],{"trials":824,"activeCount":97},[],{"trials":826,"activeCount":97},[827],{"nctId":453,"briefTitle":454,"status":290,"phases":828,"primaryCompletion":456,"completion":457,"start":458,"enrollment":459,"conditions":829,"interventions":830},[89],[461],[426,447,463,464],{"trials":832,"activeCount":97},[],{"intervention":464,"totalTrials":93,"cells":834},{"EARLY_PHASE1":835,"PHASE1":837,"PHASE2":839,"PHASE3":841,"PHASE4":843,"NA":849},{"trials":836,"activeCount":97},[],{"trials":838,"activeCount":97},[],{"trials":840,"activeCount":97},[],{"trials":842,"activeCount":97},[],{"trials":844,"activeCount":97},[845],{"nctId":453,"briefTitle":454,"status":290,"phases":846,"primaryCompletion":456,"completion":457,"start":458,"enrollment":459,"conditions":847,"interventions":848},[89],[461],[426,447,463,464],{"trials":850,"activeCount":97},[],{"intervention":852,"totalTrials":93,"cells":853},"Probiotic Formula",{"EARLY_PHASE1":854,"PHASE1":856,"PHASE2":858,"PHASE3":860,"PHASE4":862,"NA":873},{"trials":855,"activeCount":97},[],{"trials":857,"activeCount":97},[],{"trials":859,"activeCount":97},[],{"trials":861,"activeCount":97},[],{"trials":863,"activeCount":97},[864],{"nctId":865,"briefTitle":866,"status":290,"phases":867,"primaryCompletion":868,"completion":868,"start":869,"enrollment":870,"conditions":871,"interventions":872},"NCT03251625","Multi-strain Probiotic in the Management of IBS-D",[89],"2016-04","2015-04",400,[545],[852],{"trials":874,"activeCount":97},[],{"intervention":876,"totalTrials":93,"cells":877},"group A : Amoxicillin Esomeprazole HDDT",{"EARLY_PHASE1":878,"PHASE1":880,"PHASE2":882,"PHASE3":884,"PHASE4":886,"NA":898},{"trials":879,"activeCount":97},[],{"trials":881,"activeCount":97},[],{"trials":883,"activeCount":97},[],{"trials":885,"activeCount":97},[],{"trials":887,"activeCount":97},[888],{"nctId":889,"briefTitle":890,"status":397,"phases":891,"primaryCompletion":892,"completion":892,"start":893,"enrollment":278,"conditions":894,"interventions":896},"NCT06088316","Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT",[89],"2024-02","2023-02-10",[112,895],"Helicobacter Pylori Eradication",[876,897],"group-B : Levofloxacin triple therapy",{"trials":899,"activeCount":97},[],{"intervention":897,"totalTrials":93,"cells":901},{"EARLY_PHASE1":902,"PHASE1":904,"PHASE2":906,"PHASE3":908,"PHASE4":910,"NA":916},{"trials":903,"activeCount":97},[],{"trials":905,"activeCount":97},[],{"trials":907,"activeCount":97},[],{"trials":909,"activeCount":97},[],{"trials":911,"activeCount":97},[912],{"nctId":889,"briefTitle":890,"status":397,"phases":913,"primaryCompletion":892,"completion":892,"start":893,"enrollment":278,"conditions":914,"interventions":915},[89],[112,895],[876,897],{"trials":917,"activeCount":97},[],{"intervention":919,"totalTrials":93,"cells":920},"Indomethacin SR, 75 Mg Oral Capsule, Extended Release",{"EARLY_PHASE1":921,"PHASE1":923,"PHASE2":925,"PHASE3":927,"PHASE4":929,"NA":943},{"trials":922,"activeCount":97},[],{"trials":924,"activeCount":97},[],{"trials":926,"activeCount":97},[],{"trials":928,"activeCount":97},[],{"trials":930,"activeCount":97},[931],{"nctId":932,"briefTitle":933,"status":290,"phases":934,"primaryCompletion":935,"completion":935,"start":936,"enrollment":937,"conditions":938,"interventions":939},"NCT03582332","Serum Creatinine Change \u002F Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients",[89],"2016-06-23","2016-01-02",64,[421],[919,940,941,942],"Indomethacin 25 Mg Oral","Etoricoxib 90 mg","Etoricoxib 60 mg",{"trials":944,"activeCount":97},[],{"intervention":940,"totalTrials":93,"cells":946},{"EARLY_PHASE1":947,"PHASE1":949,"PHASE2":951,"PHASE3":953,"PHASE4":955,"NA":961},{"trials":948,"activeCount":97},[],{"trials":950,"activeCount":97},[],{"trials":952,"activeCount":97},[],{"trials":954,"activeCount":97},[],{"trials":956,"activeCount":97},[957],{"nctId":932,"briefTitle":933,"status":290,"phases":958,"primaryCompletion":935,"completion":935,"start":936,"enrollment":937,"conditions":959,"interventions":960},[89],[421],[919,940,941,942],{"trials":962,"activeCount":97},[],{"intervention":941,"totalTrials":93,"cells":964},{"EARLY_PHASE1":965,"PHASE1":967,"PHASE2":969,"PHASE3":971,"PHASE4":973,"NA":979},{"trials":966,"activeCount":97},[],{"trials":968,"activeCount":97},[],{"trials":970,"activeCount":97},[],{"trials":972,"activeCount":97},[],{"trials":974,"activeCount":97},[975],{"nctId":932,"briefTitle":933,"status":290,"phases":976,"primaryCompletion":935,"completion":935,"start":936,"enrollment":937,"conditions":977,"interventions":978},[89],[421],[919,940,941,942],{"trials":980,"activeCount":97},[],{"intervention":942,"totalTrials":93,"cells":982},{"EARLY_PHASE1":983,"PHASE1":985,"PHASE2":987,"PHASE3":989,"PHASE4":991,"NA":997},{"trials":984,"activeCount":97},[],{"trials":986,"activeCount":97},[],{"trials":988,"activeCount":97},[],{"trials":990,"activeCount":97},[],{"trials":992,"activeCount":97},[993],{"nctId":932,"briefTitle":933,"status":290,"phases":994,"primaryCompletion":935,"completion":935,"start":936,"enrollment":937,"conditions":995,"interventions":996},[89],[421],[919,940,941,942],{"trials":998,"activeCount":97},[],{"intervention":1000,"totalTrials":93,"cells":1001},"Silodosin",{"EARLY_PHASE1":1002,"PHASE1":1004,"PHASE2":1006,"PHASE3":1008,"PHASE4":1010,"NA":1023},{"trials":1003,"activeCount":97},[],{"trials":1005,"activeCount":97},[],{"trials":1007,"activeCount":97},[],{"trials":1009,"activeCount":97},[],{"trials":1011,"activeCount":97},[1012],{"nctId":1013,"briefTitle":1014,"status":290,"phases":1015,"primaryCompletion":1016,"completion":1016,"start":1017,"enrollment":1018,"conditions":1019,"interventions":1021},"NCT04107896","Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)",[89],"2018-08-31","2017-08-31",141,[1020],"Benign Prostatic Hyperplasia",[1000,1022],"Tamsulosin",{"trials":1024,"activeCount":97},[],{"intervention":1022,"totalTrials":93,"cells":1026},{"EARLY_PHASE1":1027,"PHASE1":1029,"PHASE2":1031,"PHASE3":1033,"PHASE4":1035,"NA":1041},{"trials":1028,"activeCount":97},[],{"trials":1030,"activeCount":97},[],{"trials":1032,"activeCount":97},[],{"trials":1034,"activeCount":97},[],{"trials":1036,"activeCount":97},[1037],{"nctId":1013,"briefTitle":1014,"status":290,"phases":1038,"primaryCompletion":1016,"completion":1016,"start":1017,"enrollment":1018,"conditions":1039,"interventions":1040},[89],[1020],[1000,1022],{"trials":1042,"activeCount":97},[],{"intervention":1044,"totalTrials":93,"cells":1045},"Fentanyl",{"EARLY_PHASE1":1046,"PHASE1":1048,"PHASE2":1050,"PHASE3":1052,"PHASE4":1054,"NA":1066},{"trials":1047,"activeCount":97},[],{"trials":1049,"activeCount":97},[],{"trials":1051,"activeCount":97},[],{"trials":1053,"activeCount":97},[],{"trials":1055,"activeCount":97},[1056],{"nctId":1057,"briefTitle":1058,"status":397,"phases":1059,"primaryCompletion":1060,"completion":1060,"start":1061,"enrollment":1062,"conditions":1063,"interventions":1065},"NCT04937946","Efficacy and Safety of Fentanyl for Pain Control in Newborn on Mechanical Ventilation",[89],"2022-07-01","2021-08-01",40,[1064],"Mechanical Ventilation Complication",[1044],{"trials":1067,"activeCount":97},[],{"intervention":521,"totalTrials":93,"cells":1069},{"EARLY_PHASE1":1070,"PHASE1":1072,"PHASE2":1074,"PHASE3":1076,"PHASE4":1078,"NA":1084},{"trials":1071,"activeCount":97},[],{"trials":1073,"activeCount":97},[],{"trials":1075,"activeCount":97},[],{"trials":1077,"activeCount":97},[],{"trials":1079,"activeCount":97},[1080],{"nctId":512,"briefTitle":513,"status":397,"phases":1081,"primaryCompletion":515,"completion":516,"start":517,"enrollment":518,"conditions":1082,"interventions":1083},[89],[503],[490,521,522],{"trials":1085,"activeCount":97},[],{"intervention":522,"totalTrials":93,"cells":1087},{"EARLY_PHASE1":1088,"PHASE1":1090,"PHASE2":1092,"PHASE3":1094,"PHASE4":1096,"NA":1102},{"trials":1089,"activeCount":97},[],{"trials":1091,"activeCount":97},[],{"trials":1093,"activeCount":97},[],{"trials":1095,"activeCount":97},[],{"trials":1097,"activeCount":97},[1098],{"nctId":512,"briefTitle":513,"status":397,"phases":1099,"primaryCompletion":515,"completion":516,"start":517,"enrollment":518,"conditions":1100,"interventions":1101},[89],[503],[490,521,522],{"trials":1103,"activeCount":97},[],{"intervention":583,"totalTrials":93,"cells":1105},{"EARLY_PHASE1":1106,"PHASE1":1108,"PHASE2":1110,"PHASE3":1112,"PHASE4":1114,"NA":1120},{"trials":1107,"activeCount":97},[],{"trials":1109,"activeCount":97},[],{"trials":1111,"activeCount":97},[],{"trials":1113,"activeCount":97},[],{"trials":1115,"activeCount":97},[1116],{"nctId":576,"briefTitle":577,"status":397,"phases":1117,"primaryCompletion":438,"completion":438,"start":579,"enrollment":580,"conditions":1118,"interventions":1119},[89],[30],[563,583],{"trials":1121,"activeCount":97},[],{"intervention":1123,"totalTrials":93,"cells":1124},"Prednisolone",{"EARLY_PHASE1":1125,"PHASE1":1127,"PHASE2":1129,"PHASE3":1131,"PHASE4":1133,"NA":1145},{"trials":1126,"activeCount":97},[],{"trials":1128,"activeCount":97},[],{"trials":1130,"activeCount":97},[],{"trials":1132,"activeCount":97},[],{"trials":1134,"activeCount":97},[1135],{"nctId":1136,"briefTitle":1137,"status":290,"phases":1138,"primaryCompletion":1139,"completion":1139,"start":1140,"enrollment":1141,"conditions":1142,"interventions":1144},"NCT04146220","Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus Nephritis",[89],"2019-09-30","2018-07-16",32,[1143],"Lupus Nephritis",[1123],{"trials":1146,"activeCount":97},[],{"intervention":1148,"totalTrials":93,"cells":1149},"Albumin infusion, 2g\u002FL of ascitic fluid aspiration.",{"EARLY_PHASE1":1150,"PHASE1":1152,"PHASE2":1154,"PHASE3":1156,"PHASE4":1158,"NA":1169},{"trials":1151,"activeCount":97},[],{"trials":1153,"activeCount":97},[],{"trials":1155,"activeCount":97},[],{"trials":1157,"activeCount":97},[],{"trials":1159,"activeCount":97},[1160],{"nctId":1161,"briefTitle":1162,"status":290,"phases":1163,"primaryCompletion":1164,"completion":1164,"start":1165,"enrollment":361,"conditions":1166,"interventions":1168},"NCT06892535","Low-dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis (LVP) in Decompensated Cirrhosis Liver.",[89],"2025-02-28","2024-02-02",[1167],"Paracentesis-Induced Circulatory Dysfunction",[1148],{"trials":1170,"activeCount":97},[],{"intervention":593,"totalTrials":93,"cells":1172},{"EARLY_PHASE1":1173,"PHASE1":1175,"PHASE2":1177,"PHASE3":1179,"PHASE4":1181,"NA":1187},{"trials":1174,"activeCount":97},[],{"trials":1176,"activeCount":97},[],{"trials":1178,"activeCount":97},[],{"trials":1180,"activeCount":97},[],{"trials":1182,"activeCount":97},[1183],{"nctId":585,"briefTitle":586,"status":290,"phases":1184,"primaryCompletion":588,"completion":588,"start":589,"enrollment":590,"conditions":1185,"interventions":1186},[89],[30],[593,563],{"trials":1188,"activeCount":97},[],{"intervention":1190,"totalTrials":93,"cells":1191},"Tofacitinib 5 mg,",{"EARLY_PHASE1":1192,"PHASE1":1194,"PHASE2":1196,"PHASE3":1198,"PHASE4":1200,"NA":1214},{"trials":1193,"activeCount":97},[],{"trials":1195,"activeCount":97},[],{"trials":1197,"activeCount":97},[],{"trials":1199,"activeCount":97},[],{"trials":1201,"activeCount":97},[1202],{"nctId":1203,"briefTitle":1204,"status":397,"phases":1205,"primaryCompletion":1206,"completion":1207,"start":1208,"enrollment":1209,"conditions":1210,"interventions":1212},"NCT03504072","Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh",[89],"2019-06-30","2019-12-31","2018-01-16",174,[1211],"Spondyloarthritis",[1190,1213],"Etanercept",{"trials":1215,"activeCount":97},[],{"intervention":1213,"totalTrials":93,"cells":1217},{"EARLY_PHASE1":1218,"PHASE1":1220,"PHASE2":1222,"PHASE3":1224,"PHASE4":1226,"NA":1232},{"trials":1219,"activeCount":97},[],{"trials":1221,"activeCount":97},[],{"trials":1223,"activeCount":97},[],{"trials":1225,"activeCount":97},[],{"trials":1227,"activeCount":97},[1228],{"nctId":1203,"briefTitle":1204,"status":397,"phases":1229,"primaryCompletion":1206,"completion":1207,"start":1208,"enrollment":1209,"conditions":1230,"interventions":1231},[89],[1211],[1190,1213],{"trials":1233,"activeCount":97},[],{"intervention":1235,"totalTrials":93,"cells":1236},"Ivabradine",{"EARLY_PHASE1":1237,"PHASE1":1239,"PHASE2":1241,"PHASE3":1243,"PHASE4":1245,"NA":1259},{"trials":1238,"activeCount":97},[],{"trials":1240,"activeCount":97},[],{"trials":1242,"activeCount":97},[],{"trials":1244,"activeCount":97},[],{"trials":1246,"activeCount":97},[1247],{"nctId":1248,"briefTitle":1249,"status":290,"phases":1250,"primaryCompletion":1251,"completion":1252,"start":1253,"enrollment":1254,"conditions":1255,"interventions":1257},"NCT06371222","Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm",[89],"2024-01-31","2024-02-01","2023-02-01",42,[1256],"Mitral Stenosis",[1235,1258],"Beta blocker",{"trials":1260,"activeCount":97},[],{"intervention":1258,"totalTrials":93,"cells":1262},{"EARLY_PHASE1":1263,"PHASE1":1265,"PHASE2":1267,"PHASE3":1269,"PHASE4":1271,"NA":1277},{"trials":1264,"activeCount":97},[],{"trials":1266,"activeCount":97},[],{"trials":1268,"activeCount":97},[],{"trials":1270,"activeCount":97},[],{"trials":1272,"activeCount":97},[1273],{"nctId":1248,"briefTitle":1249,"status":290,"phases":1274,"primaryCompletion":1251,"completion":1252,"start":1253,"enrollment":1254,"conditions":1275,"interventions":1276},[89],[1256],[1235,1258],{"trials":1278,"activeCount":97},[],{"intervention":1280,"totalTrials":93,"cells":1281},"Autologous Adipose Tissue-Derived Mesenchymal Stem Cell",{"EARLY_PHASE1":1282,"PHASE1":1284,"PHASE2":1286,"PHASE3":1288,"PHASE4":1301,"NA":1303},{"trials":1283,"activeCount":97},[],{"trials":1285,"activeCount":97},[],{"trials":1287,"activeCount":97},[],{"trials":1289,"activeCount":97},[1290],{"nctId":1291,"briefTitle":1292,"status":397,"phases":1293,"primaryCompletion":1294,"completion":1295,"start":1296,"enrollment":1297,"conditions":1298,"interventions":1300},"NCT05783154","Effect of Mesenchymal Stem Cells in Primary Knee Osteoarthritis",[87,88],"2024-07-31","2024-09-30","2022-09-16",84,[1299],"Osteoarthritis Knee",[1280],{"trials":1302,"activeCount":97},[],{"trials":1304,"activeCount":97},[],{"intervention":1306,"totalTrials":93,"cells":1307},"Co-trimoxazole",{"EARLY_PHASE1":1308,"PHASE1":1310,"PHASE2":1312,"PHASE3":1314,"PHASE4":1326,"NA":1328},{"trials":1309,"activeCount":97},[],{"trials":1311,"activeCount":97},[],{"trials":1313,"activeCount":97},[],{"trials":1315,"activeCount":97},[1316],{"nctId":1317,"briefTitle":1318,"status":290,"phases":1319,"primaryCompletion":1320,"completion":1321,"start":1322,"enrollment":590,"conditions":1323,"interventions":1325},"NCT04884490","The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients",[87,88],"2021-10-14","2021-11-14","2021-05-15",[1324],"COVID-19 Pneumonia",[1306],{"trials":1327,"activeCount":97},[],{"trials":1329,"activeCount":97},[],{"intervention":1331,"totalTrials":93,"cells":1332},"Letrozol step up dose",{"EARLY_PHASE1":1333,"PHASE1":1335,"PHASE2":1337,"PHASE3":1339,"PHASE4":1352,"NA":1354},{"trials":1334,"activeCount":97},[],{"trials":1336,"activeCount":97},[],{"trials":1338,"activeCount":97},[],{"trials":1340,"activeCount":97},[1341],{"nctId":1342,"briefTitle":1343,"status":290,"phases":1344,"primaryCompletion":1345,"completion":515,"start":1346,"enrollment":278,"conditions":1347,"interventions":1350},"NCT07143682","Letrozole Step up Protocol for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome",[88],"2024-05-24","2023-01-08",[1348,1349],"Polycystic Ovarian Syndrome (PCOS)","Infertility",[1331,1351],"Conventional fixed dose letrozole",{"trials":1353,"activeCount":97},[],{"trials":1355,"activeCount":97},[],{"intervention":1351,"totalTrials":93,"cells":1357},{"EARLY_PHASE1":1358,"PHASE1":1360,"PHASE2":1362,"PHASE3":1364,"PHASE4":1370,"NA":1372},{"trials":1359,"activeCount":97},[],{"trials":1361,"activeCount":97},[],{"trials":1363,"activeCount":97},[],{"trials":1365,"activeCount":97},[1366],{"nctId":1342,"briefTitle":1343,"status":290,"phases":1367,"primaryCompletion":1345,"completion":515,"start":1346,"enrollment":278,"conditions":1368,"interventions":1369},[88],[1348,1349],[1331,1351],{"trials":1371,"activeCount":97},[],{"trials":1373,"activeCount":97},[],{"intervention":1375,"totalTrials":93,"cells":1376},"Injection Mecobalamin",{"EARLY_PHASE1":1377,"PHASE1":1379,"PHASE2":1381,"PHASE3":1383,"PHASE4":1399,"NA":1401},{"trials":1378,"activeCount":97},[],{"trials":1380,"activeCount":97},[],{"trials":1382,"activeCount":97},[],{"trials":1384,"activeCount":97},[1385],{"nctId":1386,"briefTitle":1387,"status":290,"phases":1388,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1062,"conditions":1392,"interventions":1395},"NCT03593304","Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients",[87,88],"2018-12-30","2019-03-30","2018-03-29",[1393,1394],"Vincristine Induced Neurotoxicity","Acute Lymphoblastic Leukaemia",[1375,1396,1397,1398],"Tablet Pyridoxine hydrochlorid","Normal saline","Oral Placebo",{"trials":1400,"activeCount":97},[],{"trials":1402,"activeCount":97},[],{"intervention":1396,"totalTrials":93,"cells":1404},{"EARLY_PHASE1":1405,"PHASE1":1407,"PHASE2":1409,"PHASE3":1411,"PHASE4":1417,"NA":1419},{"trials":1406,"activeCount":97},[],{"trials":1408,"activeCount":97},[],{"trials":1410,"activeCount":97},[],{"trials":1412,"activeCount":97},[1413],{"nctId":1386,"briefTitle":1387,"status":290,"phases":1414,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1062,"conditions":1415,"interventions":1416},[87,88],[1393,1394],[1375,1396,1397,1398],{"trials":1418,"activeCount":97},[],{"trials":1420,"activeCount":97},[],{"intervention":1397,"totalTrials":93,"cells":1422},{"EARLY_PHASE1":1423,"PHASE1":1425,"PHASE2":1427,"PHASE3":1429,"PHASE4":1435,"NA":1437},{"trials":1424,"activeCount":97},[],{"trials":1426,"activeCount":97},[],{"trials":1428,"activeCount":97},[],{"trials":1430,"activeCount":97},[1431],{"nctId":1386,"briefTitle":1387,"status":290,"phases":1432,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1062,"conditions":1433,"interventions":1434},[87,88],[1393,1394],[1375,1396,1397,1398],{"trials":1436,"activeCount":97},[],{"trials":1438,"activeCount":97},[],{"intervention":1398,"totalTrials":93,"cells":1440},{"EARLY_PHASE1":1441,"PHASE1":1443,"PHASE2":1445,"PHASE3":1447,"PHASE4":1453,"NA":1455},{"trials":1442,"activeCount":97},[],{"trials":1444,"activeCount":97},[],{"trials":1446,"activeCount":97},[],{"trials":1448,"activeCount":97},[1449],{"nctId":1386,"briefTitle":1387,"status":290,"phases":1450,"primaryCompletion":1389,"completion":1390,"start":1391,"enrollment":1062,"conditions":1451,"interventions":1452},[87,88],[1393,1394],[1375,1396,1397,1398],{"trials":1454,"activeCount":97},[],{"trials":1456,"activeCount":97},[],{"intervention":1458,"totalTrials":93,"cells":1459},"Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study from Bangladesh",{"EARLY_PHASE1":1460,"PHASE1":1462,"PHASE2":1464,"PHASE3":1466,"PHASE4":1476,"NA":1478},{"trials":1461,"activeCount":97},[],{"trials":1463,"activeCount":97},[],{"trials":1465,"activeCount":97},[],{"trials":1467,"activeCount":97},[1468],{"nctId":1469,"briefTitle":1470,"status":290,"phases":1471,"primaryCompletion":657,"completion":657,"start":458,"enrollment":1472,"conditions":1473,"interventions":1475},"NCT06985134","Comparative Efficacy and Safety of Thalidomide and Sulfasalazine in Moderate to Severe Ankylosing Spondylitis: A Real-World Study From Bangladesh",[88],93,[1470,1474],"Condition ...Moderate to Severe Axial Spondyloarthopathy",[1458],{"trials":1477,"activeCount":97},[],{"trials":1479,"activeCount":97},[],{"intervention":1481,"totalTrials":93,"cells":1482},"Rosuvastatin",{"EARLY_PHASE1":1483,"PHASE1":1485,"PHASE2":1487,"PHASE3":1489,"PHASE4":1502,"NA":1504},{"trials":1484,"activeCount":97},[],{"trials":1486,"activeCount":97},[],{"trials":1488,"activeCount":97},[],{"trials":1490,"activeCount":97},[1491],{"nctId":1492,"briefTitle":1493,"status":397,"phases":1494,"primaryCompletion":1495,"completion":1496,"start":1497,"enrollment":518,"conditions":1498,"interventions":1500},"NCT02979704","A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia",[87,88],"2017-06","2017-07","2016-09",[1499],"Hyperlipidemia",[1481,1501],"Atorvastatin",{"trials":1503,"activeCount":97},[],{"trials":1505,"activeCount":97},[],{"intervention":1501,"totalTrials":93,"cells":1507},{"EARLY_PHASE1":1508,"PHASE1":1510,"PHASE2":1512,"PHASE3":1514,"PHASE4":1520,"NA":1522},{"trials":1509,"activeCount":97},[],{"trials":1511,"activeCount":97},[],{"trials":1513,"activeCount":97},[],{"trials":1515,"activeCount":97},[1516],{"nctId":1492,"briefTitle":1493,"status":397,"phases":1517,"primaryCompletion":1495,"completion":1496,"start":1497,"enrollment":518,"conditions":1518,"interventions":1519},[87,88],[1499],[1481,1501],{"trials":1521,"activeCount":97},[],{"trials":1523,"activeCount":97},[],{"intervention":1525,"totalTrials":93,"cells":1526},"Carica Papaya Leaf Extract",{"EARLY_PHASE1":1527,"PHASE1":1529,"PHASE2":1531,"PHASE3":1533,"PHASE4":1546,"NA":1548},{"trials":1528,"activeCount":97},[],{"trials":1530,"activeCount":97},[],{"trials":1532,"activeCount":97},[],{"trials":1534,"activeCount":97},[1535],{"nctId":1536,"briefTitle":1537,"status":290,"phases":1538,"primaryCompletion":1539,"completion":1540,"start":1541,"enrollment":1542,"conditions":1543,"interventions":1545},"NCT06121934","Efficacy and Safety of Carica Papaya in Dengue Fever: A Randomised Clinical Trial",[88],"2023-12-20","2023-12-27","2023-10-01",250,[1544],"Dengue",[1525],{"trials":1547,"activeCount":97},[],{"trials":1549,"activeCount":97},[],{"intervention":1551,"totalTrials":93,"cells":1552},"Brinjal peel extract containing cream",{"EARLY_PHASE1":1553,"PHASE1":1555,"PHASE2":1557,"PHASE3":1568,"PHASE4":1570,"NA":1572},{"trials":1554,"activeCount":97},[],{"trials":1556,"activeCount":97},[],{"trials":1558,"activeCount":97},[1559],{"nctId":1560,"briefTitle":1561,"status":397,"phases":1562,"primaryCompletion":457,"completion":1563,"start":1564,"enrollment":1565,"conditions":1566,"interventions":1567},"NCT03641079","Identification of Compound From Brinjal Peel Extract in the Treatment of Palmar Arsenical Keratosis and Bowen's Disease",[87],"2019-02","2017-09-16",36,[17],[1551],{"trials":1569,"activeCount":97},[],{"trials":1571,"activeCount":97},[],{"trials":1573,"activeCount":97},[],{"intervention":1575,"totalTrials":93,"cells":1576},"Cock's comb extract 0.01%",{"EARLY_PHASE1":1577,"PHASE1":1579,"PHASE2":1581,"PHASE3":1592,"PHASE4":1594,"NA":1596},{"trials":1578,"activeCount":97},[],{"trials":1580,"activeCount":97},[],{"trials":1582,"activeCount":97},[1583],{"nctId":1584,"briefTitle":1585,"status":290,"phases":1586,"primaryCompletion":1587,"completion":1587,"start":1588,"enrollment":1589,"conditions":1590,"interventions":1591},"NCT03127657","Effect of Cock's Comb Extract in the Treatment of Arsenical Skin Lesion",[87],"2018-01-31","2016-01-17",25,[14],[1575],{"trials":1593,"activeCount":97},[],{"trials":1595,"activeCount":97},[],{"trials":1597,"activeCount":97},[],{"intervention":1599,"totalTrials":93,"cells":1600},"Magnesium and Vitamin B6",{"EARLY_PHASE1":1601,"PHASE1":1603,"PHASE2":1605,"PHASE3":1617,"PHASE4":1619,"NA":1621},{"trials":1602,"activeCount":97},[],{"trials":1604,"activeCount":97},[],{"trials":1606,"activeCount":97},[1607],{"nctId":1608,"briefTitle":1609,"status":397,"phases":1610,"primaryCompletion":1611,"completion":1611,"start":1612,"enrollment":1613,"conditions":1614,"interventions":1616},"NCT03963479","Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients",[87],"2019-07-31","2019-01-01",50,[1615],"Autism Spectrum Disorder",[1599],{"trials":1618,"activeCount":97},[],{"trials":1620,"activeCount":97},[],{"trials":1622,"activeCount":97},[],{"intervention":1624,"totalTrials":93,"cells":1625},"Vitamin E",{"EARLY_PHASE1":1626,"PHASE1":1628,"PHASE2":1630,"PHASE3":1642,"PHASE4":1644,"NA":1646},{"trials":1627,"activeCount":97},[],{"trials":1629,"activeCount":97},[],{"trials":1631,"activeCount":97},[1632],{"nctId":1633,"briefTitle":1634,"status":290,"phases":1635,"primaryCompletion":1636,"completion":1637,"start":1638,"enrollment":1639,"conditions":1640,"interventions":1641},"NCT02468518","Effect of Vitamin E on Skin Aerobic Bacteria in Palmar Arsenical Keratosis",[87],"2015-12","2016-01","2015-03",45,[14],[1624],{"trials":1643,"activeCount":97},[],{"trials":1645,"activeCount":97},[],{"trials":1647,"activeCount":97},[],{"intervention":445,"totalTrials":93,"cells":1649},{"EARLY_PHASE1":1650,"PHASE1":1652,"PHASE2":1654,"PHASE3":1660,"PHASE4":1662,"NA":1664},{"trials":1651,"activeCount":97},[],{"trials":1653,"activeCount":97},[],{"trials":1655,"activeCount":97},[1656],{"nctId":435,"briefTitle":436,"status":397,"phases":1657,"primaryCompletion":438,"completion":439,"start":440,"enrollment":441,"conditions":1658,"interventions":1659},[87],[443],[445,446,426,447],{"trials":1661,"activeCount":97},[],{"trials":1663,"activeCount":97},[],{"trials":1665,"activeCount":97},[],{"intervention":446,"totalTrials":93,"cells":1667},{"EARLY_PHASE1":1668,"PHASE1":1670,"PHASE2":1672,"PHASE3":1678,"PHASE4":1680,"NA":1682},{"trials":1669,"activeCount":97},[],{"trials":1671,"activeCount":97},[],{"trials":1673,"activeCount":97},[1674],{"nctId":435,"briefTitle":436,"status":397,"phases":1675,"primaryCompletion":438,"completion":439,"start":440,"enrollment":441,"conditions":1676,"interventions":1677},[87],[443],[445,446,426,447],{"trials":1679,"activeCount":97},[],{"trials":1681,"activeCount":97},[],{"trials":1683,"activeCount":97},[],{"intervention":1685,"totalTrials":93,"cells":1686},"Pizotifen",{"EARLY_PHASE1":1687,"PHASE1":1689,"PHASE2":1691,"PHASE3":1704,"PHASE4":1706,"NA":1708},{"trials":1688,"activeCount":97},[],{"trials":1690,"activeCount":97},[],{"trials":1692,"activeCount":97},[1693],{"nctId":1694,"briefTitle":1695,"status":397,"phases":1696,"primaryCompletion":1697,"completion":1698,"start":1699,"enrollment":556,"conditions":1700,"interventions":1702},"NCT06158230","Comparison of Efficacy Between Combination of Amitriptyline-propranolol and Pizotifen for Migraine Prophylaxis.",[87],"2023-11-25","2024-01-15","2023-03-19",[1701],"Migraine",[1685,1703],"Amitriptyline-propranolol",{"trials":1705,"activeCount":97},[],{"trials":1707,"activeCount":97},[],{"trials":1709,"activeCount":97},[],{"intervention":1703,"totalTrials":93,"cells":1711},{"EARLY_PHASE1":1712,"PHASE1":1714,"PHASE2":1716,"PHASE3":1722,"PHASE4":1724,"NA":1726},{"trials":1713,"activeCount":97},[],{"trials":1715,"activeCount":97},[],{"trials":1717,"activeCount":97},[1718],{"nctId":1694,"briefTitle":1695,"status":397,"phases":1719,"primaryCompletion":1697,"completion":1698,"start":1699,"enrollment":556,"conditions":1720,"interventions":1721},[87],[1701],[1685,1703],{"trials":1723,"activeCount":97},[],{"trials":1725,"activeCount":97},[],{"trials":1727,"activeCount":97},[],{"intervention":1729,"totalTrials":93,"cells":1730},"lidocaine transdermal patch",{"EARLY_PHASE1":1731,"PHASE1":1733,"PHASE2":1735,"PHASE3":1746,"PHASE4":1748,"NA":1750},{"trials":1732,"activeCount":97},[],{"trials":1734,"activeCount":97},[],{"trials":1736,"activeCount":97},[1737],{"nctId":1738,"briefTitle":1739,"status":397,"phases":1740,"primaryCompletion":1741,"completion":1741,"start":1742,"enrollment":518,"conditions":1743,"interventions":1745},"NCT05866653","Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients",[87],"2023-07-30","2023-03-25",[1744],"Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients",[1729],{"trials":1747,"activeCount":97},[],{"trials":1749,"activeCount":97},[],{"trials":1751,"activeCount":97},[],{"intervention":1753,"totalTrials":93,"cells":1754},"oral co-trimoxazole",{"EARLY_PHASE1":1755,"PHASE1":1757,"PHASE2":1759,"PHASE3":1771,"PHASE4":1773,"NA":1775},{"trials":1756,"activeCount":97},[],{"trials":1758,"activeCount":97},[],{"trials":1760,"activeCount":97},[1761],{"nctId":1762,"briefTitle":1763,"status":397,"phases":1764,"primaryCompletion":1765,"completion":1766,"start":1767,"enrollment":590,"conditions":1768,"interventions":1770},"NCT04470531","Role of Co-trimoxazole in Severe COVID-19 Patients",[87],"2020-10-12","2021-01-30","2020-07-12",[23,1769],"Severe COVID-19 Patients",[1753],{"trials":1772,"activeCount":97},[],{"trials":1774,"activeCount":97},[],{"trials":1776,"activeCount":97},[],{"intervention":1778,"totalTrials":93,"cells":1779},"Iron 150 mg and Folic acid 0.5 mg",{"EARLY_PHASE1":1780,"PHASE1":1782,"PHASE2":1784,"PHASE3":1794,"PHASE4":1796,"NA":1798},{"trials":1781,"activeCount":97},[],{"trials":1783,"activeCount":97},[],{"trials":1785,"activeCount":97},[1786],{"nctId":1787,"briefTitle":1788,"status":290,"phases":1789,"primaryCompletion":1790,"completion":1496,"start":1791,"enrollment":1254,"conditions":1792,"interventions":1793},"NCT02908581","Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis",[87],"2017-04","2016-06",[14],[1778],{"trials":1795,"activeCount":97},[],{"trials":1797,"activeCount":97},[],{"trials":1799,"activeCount":97},[],{"intervention":1801,"totalTrials":93,"cells":1802},"Doxycycline",{"EARLY_PHASE1":1803,"PHASE1":1805,"PHASE2":1807,"PHASE3":1816,"PHASE4":1818,"NA":1820},{"trials":1804,"activeCount":97},[],{"trials":1806,"activeCount":97},[],{"trials":1808,"activeCount":97},[1809],{"nctId":1810,"briefTitle":1811,"status":397,"phases":1812,"primaryCompletion":1813,"completion":1813,"start":1060,"enrollment":459,"conditions":1814,"interventions":1815},"NCT05492019","Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients",[87],"2023-01-01",[26],[1801],{"trials":1817,"activeCount":97},[],{"trials":1819,"activeCount":97},[],{"trials":1821,"activeCount":97},[],{"intervention":1823,"totalTrials":93,"cells":1824},"Metformin 500 Mg extended release Oral",{"EARLY_PHASE1":1825,"PHASE1":1827,"PHASE2":1829,"PHASE3":1839,"PHASE4":1841,"NA":1843},{"trials":1826,"activeCount":97},[],{"trials":1828,"activeCount":97},[],{"trials":1830,"activeCount":97},[1831],{"nctId":1832,"briefTitle":1833,"status":397,"phases":1834,"primaryCompletion":439,"completion":515,"start":1835,"enrollment":320,"conditions":1836,"interventions":1838},"NCT06126029","Effect of Metformin as Add-on Therapy to Ibuprofen on Disease Activity in Knee Osteoarthritis Patients.",[87],"2023-10-15",[1837,48],"Knee Osteoarthritis",[1823],{"trials":1840,"activeCount":97},[],{"trials":1842,"activeCount":97},[],{"trials":1844,"activeCount":97},[],{"intervention":1846,"totalTrials":93,"cells":1847},"Convalescent plasma",{"EARLY_PHASE1":1848,"PHASE1":1850,"PHASE2":1852,"PHASE3":1865,"PHASE4":1867,"NA":1869},{"trials":1849,"activeCount":97},[],{"trials":1851,"activeCount":97},[],{"trials":1853,"activeCount":97},[1854],{"nctId":1855,"briefTitle":1856,"status":397,"phases":1857,"primaryCompletion":1858,"completion":1859,"start":1860,"enrollment":1861,"conditions":1862,"interventions":1864},"NCT04403477","Convalescent Plasma Therapy in Severe COVID-19 Infection",[87],"2020-07-20","2020-10-30","2020-05-20",20,[23,1863],"Convalescence",[1846],{"trials":1866,"activeCount":97},[],{"trials":1868,"activeCount":97},[],{"trials":1870,"activeCount":97},[],{"intervention":1872,"totalTrials":93,"cells":1873},"drug containing extract from cock's comb",{"EARLY_PHASE1":1874,"PHASE1":1876,"PHASE2":1878,"PHASE3":1887,"PHASE4":1889,"NA":1891},{"trials":1875,"activeCount":97},[],{"trials":1877,"activeCount":97},[],{"trials":1879,"activeCount":97},[1880],{"nctId":1881,"briefTitle":1882,"status":397,"phases":1883,"primaryCompletion":457,"completion":1563,"start":1564,"enrollment":1062,"conditions":1884,"interventions":1886},"NCT03635853","Identification of Compound Isolated From Cock's Comb and Its Effect on Arsenical Palmar Keratosis",[87],[1885],"Improvement of Keratotic Nodular Size",[1872],{"trials":1888,"activeCount":97},[],{"trials":1890,"activeCount":97},[],{"trials":1892,"activeCount":97},[],{"intervention":1894,"totalTrials":93,"cells":1895},"Metformin and doxycycline",{"EARLY_PHASE1":1896,"PHASE1":1898,"PHASE2":1900,"PHASE3":1912,"PHASE4":1914,"NA":1916},{"trials":1897,"activeCount":97},[],{"trials":1899,"activeCount":97},[],{"trials":1901,"activeCount":97},[1902],{"nctId":1903,"briefTitle":1904,"status":397,"phases":1905,"primaryCompletion":1906,"completion":1906,"start":1907,"enrollment":1908,"conditions":1909,"interventions":1911},"NCT06252194","Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.",[87],"2024-03","2023-03-05",120,[1910],"Acne Vulgaris",[1894],{"trials":1913,"activeCount":97},[],{"trials":1915,"activeCount":97},[],{"trials":1917,"activeCount":97},[],{"intervention":1919,"totalTrials":93,"cells":1920},"Pumpkin seed extract containing cream",{"EARLY_PHASE1":1921,"PHASE1":1923,"PHASE2":1925,"PHASE3":1936,"PHASE4":1938,"NA":1940},{"trials":1922,"activeCount":97},[],{"trials":1924,"activeCount":97},[],{"trials":1926,"activeCount":97},[1927],{"nctId":1928,"briefTitle":1929,"status":397,"phases":1930,"primaryCompletion":1931,"completion":1931,"start":1932,"enrollment":1933,"conditions":1934,"interventions":1935},"NCT04608461","Effect of Pumpkin Seeds in the Treatment of Moderate to Severe Palmar Arsenical Keratosis",[87],"2020-12-05","2019-09-17",23,[17],[1919],{"trials":1937,"activeCount":97},[],{"trials":1939,"activeCount":97},[],{"trials":1941,"activeCount":97},[],{"intervention":1943,"totalTrials":93,"cells":1944},"Pegalyted interferon, Entecavir",{"EARLY_PHASE1":1945,"PHASE1":1947,"PHASE2":1949,"PHASE3":1961,"PHASE4":1963,"NA":1965},{"trials":1946,"activeCount":97},[],{"trials":1948,"activeCount":97},[],{"trials":1950,"activeCount":97},[1951],{"nctId":1952,"briefTitle":1953,"status":397,"phases":1954,"primaryCompletion":1955,"completion":1956,"start":1957,"enrollment":1861,"conditions":1958,"interventions":1960},"NCT01589952","Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)",[86,87],"2013-02","2013-03","2012-03",[1959],"Chronic Hepatitis B",[1943],{"trials":1962,"activeCount":97},[],{"trials":1964,"activeCount":97},[],{"trials":1966,"activeCount":97},[],{"intervention":1968,"totalTrials":93,"cells":1969},"Omega 3 fatty acid",{"EARLY_PHASE1":1970,"PHASE1":1972,"PHASE2":1974,"PHASE3":1985,"PHASE4":1987,"NA":1989},{"trials":1971,"activeCount":97},[],{"trials":1973,"activeCount":97},[],{"trials":1975,"activeCount":97},[1976],{"nctId":1977,"briefTitle":1978,"status":290,"phases":1979,"primaryCompletion":1980,"completion":1981,"start":1982,"enrollment":937,"conditions":1983,"interventions":1984},"NCT06125782","Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial",[87],"2024-01-30","2024-02-05","2023-09-19",[1615],[1968],{"trials":1986,"activeCount":97},[],{"trials":1988,"activeCount":97},[],{"trials":1990,"activeCount":97},[],{"intervention":1992,"totalTrials":93,"cells":1993},"Folic Acid",{"EARLY_PHASE1":1994,"PHASE1":1996,"PHASE2":1998,"PHASE3":2008,"PHASE4":2010,"NA":2012},{"trials":1995,"activeCount":97},[],{"trials":1997,"activeCount":97},[],{"trials":1999,"activeCount":97},[2000],{"nctId":2001,"briefTitle":2002,"status":397,"phases":2003,"primaryCompletion":2004,"completion":2004,"start":2005,"enrollment":459,"conditions":2006,"interventions":2007},"NCT05959044","Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients",[87],"2024-07-16","2023-04-16",[26],[1992],{"trials":2009,"activeCount":97},[],{"trials":2011,"activeCount":97},[],{"trials":2013,"activeCount":97},[],{"intervention":2015,"totalTrials":93,"cells":2016},"Nigella Sativa capsule 500mg",{"EARLY_PHASE1":2017,"PHASE1":2019,"PHASE2":2021,"PHASE3":2031,"PHASE4":2033,"NA":2035},{"trials":2018,"activeCount":97},[],{"trials":2020,"activeCount":97},[],{"trials":2022,"activeCount":97},[2023],{"nctId":2024,"briefTitle":2025,"status":397,"phases":2026,"primaryCompletion":2027,"completion":2027,"start":2028,"enrollment":1297,"conditions":2029,"interventions":2030},"NCT06422650","Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia",[87],"2024-08-31","2023-08-24",[1499],[2015],{"trials":2032,"activeCount":97},[],{"trials":2034,"activeCount":97},[],{"trials":2036,"activeCount":97},[],{"intervention":2038,"totalTrials":93,"cells":2039},"Mirtazapine",{"EARLY_PHASE1":2040,"PHASE1":2042,"PHASE2":2044,"PHASE3":2055,"PHASE4":2057,"NA":2059},{"trials":2041,"activeCount":97},[],{"trials":2043,"activeCount":97},[],{"trials":2045,"activeCount":97},[2046],{"nctId":2047,"briefTitle":2048,"status":397,"phases":2049,"primaryCompletion":1813,"completion":1253,"start":2050,"enrollment":110,"conditions":2051,"interventions":2053},"NCT05380479","Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.",[87],"2022-06-01",[2052],"Anorexia",[2038,2054],"Megestrol Acetate",{"trials":2056,"activeCount":97},[],{"trials":2058,"activeCount":97},[],{"trials":2060,"activeCount":97},[],{"intervention":2054,"totalTrials":93,"cells":2062},{"EARLY_PHASE1":2063,"PHASE1":2065,"PHASE2":2067,"PHASE3":2073,"PHASE4":2075,"NA":2077},{"trials":2064,"activeCount":97},[],{"trials":2066,"activeCount":97},[],{"trials":2068,"activeCount":97},[2069],{"nctId":2047,"briefTitle":2048,"status":397,"phases":2070,"primaryCompletion":1813,"completion":1253,"start":2050,"enrollment":110,"conditions":2071,"interventions":2072},[87],[2052],[2038,2054],{"trials":2074,"activeCount":97},[],{"trials":2076,"activeCount":97},[],{"trials":2078,"activeCount":97},[],{"intervention":2080,"totalTrials":93,"cells":2081},"Vitamin D3",{"EARLY_PHASE1":2082,"PHASE1":2084,"PHASE2":2086,"PHASE3":2099,"PHASE4":2101,"NA":2103},{"trials":2083,"activeCount":97},[],{"trials":2085,"activeCount":97},[],{"trials":2087,"activeCount":97},[2088],{"nctId":2089,"briefTitle":2090,"status":290,"phases":2091,"primaryCompletion":439,"completion":2092,"start":2093,"enrollment":2094,"conditions":2095,"interventions":2098},"NCT06101147","Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome",[87],"2024-07-30","2023-09-21",66,[2096,2097],"PCOS","Vitamin D",[2080],{"trials":2100,"activeCount":97},[],{"trials":2102,"activeCount":97},[],{"trials":2104,"activeCount":97},[],{"intervention":2106,"totalTrials":93,"cells":2107},"Bupivacaine",{"EARLY_PHASE1":2108,"PHASE1":2110,"PHASE2":2112,"PHASE3":2123,"PHASE4":2125,"NA":2127},{"trials":2109,"activeCount":97},[],{"trials":2111,"activeCount":97},[],{"trials":2113,"activeCount":97},[2114],{"nctId":2115,"briefTitle":2116,"status":290,"phases":2117,"primaryCompletion":1611,"completion":1611,"start":1612,"enrollment":2118,"conditions":2119,"interventions":2121},"NCT03958513","To Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy",[87],58,[2120],"Post-operative Pain",[2106,2122],"0.9% normal saline",{"trials":2124,"activeCount":97},[],{"trials":2126,"activeCount":97},[],{"trials":2128,"activeCount":97},[],{"intervention":2122,"totalTrials":93,"cells":2130},{"EARLY_PHASE1":2131,"PHASE1":2133,"PHASE2":2135,"PHASE3":2141,"PHASE4":2143,"NA":2145},{"trials":2132,"activeCount":97},[],{"trials":2134,"activeCount":97},[],{"trials":2136,"activeCount":97},[2137],{"nctId":2115,"briefTitle":2116,"status":290,"phases":2138,"primaryCompletion":1611,"completion":1611,"start":1612,"enrollment":2118,"conditions":2139,"interventions":2140},[87],[2120],[2106,2122],{"trials":2142,"activeCount":97},[],{"trials":2144,"activeCount":97},[],{"trials":2146,"activeCount":97},[],{"intervention":2148,"totalTrials":93,"cells":2149},"CPLE",{"EARLY_PHASE1":2150,"PHASE1":2152,"PHASE2":2154,"PHASE3":2166,"PHASE4":2168,"NA":2170},{"trials":2151,"activeCount":97},[],{"trials":2153,"activeCount":97},[],{"trials":2155,"activeCount":97},[2156],{"nctId":2157,"briefTitle":2158,"status":290,"phases":2159,"primaryCompletion":2160,"completion":1164,"start":2161,"enrollment":2162,"conditions":2163,"interventions":2165},"NCT06945679","Effects of Carica Papaya Leaf Extract (CPLE) in the Outcome of Hospitalized Dengue Patients",[86,87],"2025-02-20","2024-06-01",184,[2164],"Dengue Fever",[2148],{"trials":2167,"activeCount":97},[],{"trials":2169,"activeCount":97},[],{"trials":2171,"activeCount":97},[],{"intervention":2173,"totalTrials":93,"cells":2174},"Arsenic Keratosis lesion or nodular size observation after 12 weeks of therapy with solasodine ointment",{"EARLY_PHASE1":2175,"PHASE1":2177,"PHASE2":2179,"PHASE3":2189,"PHASE4":2191,"NA":2193},{"trials":2176,"activeCount":97},[],{"trials":2178,"activeCount":97},[],{"trials":2180,"activeCount":97},[2181],{"nctId":2182,"briefTitle":2183,"status":397,"phases":2184,"primaryCompletion":2185,"completion":2185,"start":2186,"enrollment":1861,"conditions":2187,"interventions":2188},"NCT04693000","Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis",[87],"2021-01-15","2018-09-23",[17],[2173],{"trials":2190,"activeCount":97},[],{"trials":2192,"activeCount":97},[],{"trials":2194,"activeCount":97},[],{"intervention":2196,"totalTrials":93,"cells":2197},"Trastuzumab",{"EARLY_PHASE1":2198,"PHASE1":2200,"PHASE2":2202,"PHASE3":2216,"PHASE4":2218,"NA":2220},{"trials":2199,"activeCount":97},[],{"trials":2201,"activeCount":97},[],{"trials":2203,"activeCount":97},[2204],{"nctId":2205,"briefTitle":2206,"status":290,"phases":2207,"primaryCompletion":2208,"completion":2209,"start":2210,"enrollment":459,"conditions":2211,"interventions":2213},"NCT05997524","Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.",[87],"2022-02-28","2023-06-30","2021-03-01",[2212],"Advanced Gastric Carcinoma",[2196,2214,2215],"Oxaliplatin","Capecitabine",{"trials":2217,"activeCount":97},[],{"trials":2219,"activeCount":97},[],{"trials":2221,"activeCount":97},[],{"intervention":2214,"totalTrials":93,"cells":2223},{"EARLY_PHASE1":2224,"PHASE1":2226,"PHASE2":2228,"PHASE3":2234,"PHASE4":2236,"NA":2238},{"trials":2225,"activeCount":97},[],{"trials":2227,"activeCount":97},[],{"trials":2229,"activeCount":97},[2230],{"nctId":2205,"briefTitle":2206,"status":290,"phases":2231,"primaryCompletion":2208,"completion":2209,"start":2210,"enrollment":459,"conditions":2232,"interventions":2233},[87],[2212],[2196,2214,2215],{"trials":2235,"activeCount":97},[],{"trials":2237,"activeCount":97},[],{"trials":2239,"activeCount":97},[],{"intervention":2215,"totalTrials":93,"cells":2241},{"EARLY_PHASE1":2242,"PHASE1":2244,"PHASE2":2246,"PHASE3":2252,"PHASE4":2254,"NA":2256},{"trials":2243,"activeCount":97},[],{"trials":2245,"activeCount":97},[],{"trials":2247,"activeCount":97},[2248],{"nctId":2205,"briefTitle":2206,"status":290,"phases":2249,"primaryCompletion":2208,"completion":2209,"start":2210,"enrollment":459,"conditions":2250,"interventions":2251},[87],[2212],[2196,2214,2215],{"trials":2253,"activeCount":97},[],{"trials":2255,"activeCount":97},[],{"trials":2257,"activeCount":97},[],{"intervention":2259,"totalTrials":93,"cells":2260},"Zinc sulfate",{"EARLY_PHASE1":2261,"PHASE1":2263,"PHASE2":2265,"PHASE3":2276,"PHASE4":2278,"NA":2280},{"trials":2262,"activeCount":97},[],{"trials":2264,"activeCount":97},[],{"trials":2266,"activeCount":97},[2267],{"nctId":2268,"briefTitle":2269,"status":397,"phases":2270,"primaryCompletion":2271,"completion":2271,"start":2272,"enrollment":419,"conditions":2273,"interventions":2275},"NCT05395143","Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients",[87],"2022-07-10","2021-05-01",[2274],"Hyperlipidemias",[2259],{"trials":2277,"activeCount":97},[],{"trials":2279,"activeCount":97},[],{"trials":2281,"activeCount":97},[],{"intervention":2283,"totalTrials":93,"cells":2284},"Nicotinic Acid 500 MG Extended Release Oral",{"EARLY_PHASE1":2285,"PHASE1":2287,"PHASE2":2289,"PHASE3":2301,"PHASE4":2303,"NA":2305},{"trials":2286,"activeCount":97},[],{"trials":2288,"activeCount":97},[],{"trials":2290,"activeCount":97},[2291],{"nctId":2292,"briefTitle":2293,"status":290,"phases":2294,"primaryCompletion":2295,"completion":2295,"start":2296,"enrollment":2118,"conditions":2297,"interventions":2299},"NCT05846373","Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine",[87],"2024-01-10","2022-11-25",[2298],"Migraine Prophylaxis",[2283,2300],"Nicotinic Acid 1000 MG Extended Release Oral",{"trials":2302,"activeCount":97},[],{"trials":2304,"activeCount":97},[],{"trials":2306,"activeCount":97},[],{"intervention":2300,"totalTrials":93,"cells":2308},{"EARLY_PHASE1":2309,"PHASE1":2311,"PHASE2":2313,"PHASE3":2319,"PHASE4":2321,"NA":2323},{"trials":2310,"activeCount":97},[],{"trials":2312,"activeCount":97},[],{"trials":2314,"activeCount":97},[2315],{"nctId":2292,"briefTitle":2293,"status":290,"phases":2316,"primaryCompletion":2295,"completion":2295,"start":2296,"enrollment":2118,"conditions":2317,"interventions":2318},[87],[2298],[2283,2300],{"trials":2320,"activeCount":97},[],{"trials":2322,"activeCount":97},[],{"trials":2324,"activeCount":97},[],{"intervention":2326,"totalTrials":93,"cells":2327},"Adipose Tissue derived Total-Stromal-Cells",{"EARLY_PHASE1":2328,"PHASE1":2330,"PHASE2":2332,"PHASE3":2344,"PHASE4":2346,"NA":2348},{"trials":2329,"activeCount":97},[],{"trials":2331,"activeCount":97},[],{"trials":2333,"activeCount":97},[2334],{"nctId":2335,"briefTitle":2336,"status":290,"phases":2337,"primaryCompletion":2338,"completion":2339,"start":2340,"enrollment":11,"conditions":2341,"interventions":2343},"NCT05280002","Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis",[87],"2021-10-31","2021-12-31","2018-01-01",[2342],"Osteoarthritis Knees",[2326],{"trials":2345,"activeCount":97},[],{"trials":2347,"activeCount":97},[],{"trials":2349,"activeCount":97},[],{"intervention":2351,"totalTrials":93,"cells":2352},"Baricitinib 2mg",{"EARLY_PHASE1":2353,"PHASE1":2355,"PHASE2":2357,"PHASE3":2369,"PHASE4":2371,"NA":2373},{"trials":2354,"activeCount":97},[],{"trials":2356,"activeCount":97},[],{"trials":2358,"activeCount":97},[2359],{"nctId":2360,"briefTitle":2361,"status":397,"phases":2362,"primaryCompletion":515,"completion":2363,"start":2364,"enrollment":2162,"conditions":2365,"interventions":2367},"NCT06114407","Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib",[87],"2024-12-30","2023-10-30",[2366],"Spondyloarthritis, Axial",[2351,2368],"Tofacitinib 5 mg",{"trials":2370,"activeCount":97},[],{"trials":2372,"activeCount":97},[],{"trials":2374,"activeCount":97},[],{"intervention":2368,"totalTrials":93,"cells":2376},{"EARLY_PHASE1":2377,"PHASE1":2379,"PHASE2":2381,"PHASE3":2387,"PHASE4":2389,"NA":2391},{"trials":2378,"activeCount":97},[],{"trials":2380,"activeCount":97},[],{"trials":2382,"activeCount":97},[2383],{"nctId":2360,"briefTitle":2361,"status":397,"phases":2384,"primaryCompletion":515,"completion":2363,"start":2364,"enrollment":2162,"conditions":2385,"interventions":2386},[87],[2366],[2351,2368],{"trials":2388,"activeCount":97},[],{"trials":2390,"activeCount":97},[],{"trials":2392,"activeCount":97},[],{"intervention":2394,"totalTrials":93,"cells":2395},"Neem plus propylene glycol plus salicylic acid",{"EARLY_PHASE1":2396,"PHASE1":2398,"PHASE2":2400,"PHASE3":2410,"PHASE4":2412,"NA":2414},{"trials":2397,"activeCount":97},[],{"trials":2399,"activeCount":97},[],{"trials":2401,"activeCount":97},[2402],{"nctId":2403,"briefTitle":2404,"status":290,"phases":2405,"primaryCompletion":2406,"completion":2406,"start":1638,"enrollment":11,"conditions":2407,"interventions":2408},"NCT02352987","Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis",[87],"2015-09",[14],[2394,2409],"Salicylic acid",{"trials":2411,"activeCount":97},[],{"trials":2413,"activeCount":97},[],{"trials":2415,"activeCount":97},[],{"intervention":2417,"totalTrials":93,"cells":2418},"L-carnitine",{"EARLY_PHASE1":2419,"PHASE1":2421,"PHASE2":2423,"PHASE3":2433,"PHASE4":2435,"NA":2437},{"trials":2420,"activeCount":97},[],{"trials":2422,"activeCount":97},[],{"trials":2424,"activeCount":97},[2425],{"nctId":2426,"briefTitle":2427,"status":290,"phases":2428,"primaryCompletion":2429,"completion":2429,"start":2430,"enrollment":2094,"conditions":2431,"interventions":2432},"NCT06960694","Effect of L-carnitine on Disease Activity in Patients With Mild to Moderate Knee Osteoarthritis",[87],"2025-11-19","2025-06-28",[1837],[2417],{"trials":2434,"activeCount":97},[],{"trials":2436,"activeCount":97},[],{"trials":2438,"activeCount":97},[],{"intervention":2440,"totalTrials":93,"cells":2441},"Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution",{"EARLY_PHASE1":2442,"PHASE1":2444,"PHASE2":2446,"PHASE3":2456,"PHASE4":2458,"NA":2460},{"trials":2443,"activeCount":97},[],{"trials":2445,"activeCount":97},[],{"trials":2447,"activeCount":97},[2448],{"nctId":2449,"briefTitle":2450,"status":397,"phases":2451,"primaryCompletion":2452,"completion":2453,"start":440,"enrollment":1908,"conditions":2454,"interventions":2455},"NCT06071481","Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome",[87],"2023-12-31","2024-02-15",[2164],[2440],{"trials":2457,"activeCount":97},[],{"trials":2459,"activeCount":97},[],{"trials":2461,"activeCount":97},[],{"intervention":2463,"totalTrials":93,"cells":2464},"Tetracycline",{"EARLY_PHASE1":2465,"PHASE1":2467,"PHASE2":2469,"PHASE3":2481,"PHASE4":2483,"NA":2485},{"trials":2466,"activeCount":97},[],{"trials":2468,"activeCount":97},[],{"trials":2470,"activeCount":97},[2471],{"nctId":2472,"briefTitle":2473,"status":397,"phases":2474,"primaryCompletion":2475,"completion":657,"start":2476,"enrollment":11,"conditions":2477,"interventions":2478},"NCT03632733","Effects of Antimicrobials on the Altered Skin Flora in Arsenical Keratosis",[87],"2018-10-30","2018-01-21",[17],[2463,2479,2480],"Clotrimazole","Tetracycline and Clotrimazole",{"trials":2482,"activeCount":97},[],{"trials":2484,"activeCount":97},[],{"trials":2486,"activeCount":97},[],{"intervention":2479,"totalTrials":93,"cells":2488},{"EARLY_PHASE1":2489,"PHASE1":2491,"PHASE2":2493,"PHASE3":2499,"PHASE4":2501,"NA":2503},{"trials":2490,"activeCount":97},[],{"trials":2492,"activeCount":97},[],{"trials":2494,"activeCount":97},[2495],{"nctId":2472,"briefTitle":2473,"status":397,"phases":2496,"primaryCompletion":2475,"completion":657,"start":2476,"enrollment":11,"conditions":2497,"interventions":2498},[87],[17],[2463,2479,2480],{"trials":2500,"activeCount":97},[],{"trials":2502,"activeCount":97},[],{"trials":2504,"activeCount":97},[],{"intervention":2480,"totalTrials":93,"cells":2506},{"EARLY_PHASE1":2507,"PHASE1":2509,"PHASE2":2511,"PHASE3":2517,"PHASE4":2519,"NA":2521},{"trials":2508,"activeCount":97},[],{"trials":2510,"activeCount":97},[],{"trials":2512,"activeCount":97},[2513],{"nctId":2472,"briefTitle":2473,"status":397,"phases":2514,"primaryCompletion":2475,"completion":657,"start":2476,"enrollment":11,"conditions":2515,"interventions":2516},[87],[17],[2463,2479,2480],{"trials":2518,"activeCount":97},[],{"trials":2520,"activeCount":97},[],{"trials":2522,"activeCount":97},[],{"intervention":2524,"totalTrials":93,"cells":2525},"Astaxanthin Oral",{"EARLY_PHASE1":2526,"PHASE1":2528,"PHASE2":2530,"PHASE3":2541,"PHASE4":2543,"NA":2545},{"trials":2527,"activeCount":97},[],{"trials":2529,"activeCount":97},[],{"trials":2531,"activeCount":97},[2532],{"nctId":2533,"briefTitle":2534,"status":290,"phases":2535,"primaryCompletion":2536,"completion":2536,"start":2537,"enrollment":110,"conditions":2538,"interventions":2540},"NCT05437601","Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis",[87],"2022-12-19","2022-07-31",[2539],"Osteoarthritis, Knee",[2524],{"trials":2542,"activeCount":97},[],{"trials":2544,"activeCount":97},[],{"trials":2546,"activeCount":97},[],{"intervention":2548,"totalTrials":93,"cells":2549},"Solanum melongena peel extract 0.05%",{"EARLY_PHASE1":2550,"PHASE1":2552,"PHASE2":2554,"PHASE3":2564,"PHASE4":2566,"NA":2568},{"trials":2551,"activeCount":97},[],{"trials":2553,"activeCount":97},[],{"trials":2555,"activeCount":97},[2556],{"nctId":2557,"briefTitle":2558,"status":290,"phases":2559,"primaryCompletion":2560,"completion":2560,"start":2561,"enrollment":11,"conditions":2562,"interventions":2563},"NCT03127670","Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion",[87],"2017-12-31","2016-11-14",[20],[2548],{"trials":2565,"activeCount":97},[],{"trials":2567,"activeCount":97},[],{"trials":2569,"activeCount":97},[],{"intervention":2571,"totalTrials":93,"cells":2572},"Cabergoline plus timed intercourse",{"EARLY_PHASE1":2573,"PHASE1":2575,"PHASE2":2577,"PHASE3":2591,"PHASE4":2593,"NA":2595},{"trials":2574,"activeCount":97},[],{"trials":2576,"activeCount":97},[],{"trials":2578,"activeCount":97},[2579],{"nctId":2580,"briefTitle":2581,"status":290,"phases":2582,"primaryCompletion":2583,"completion":2584,"start":2585,"enrollment":8,"conditions":2586,"interventions":2589},"NCT06560814","Non-surgical Interventions for Infertility in Endometriosis",[87],"2021-06-21","2021-06-30","2020-07-01",[2587,2588],"Endometriosis","Infertility, Female",[2571,2590],"Dydrogesterone plus timed intercourse",{"trials":2592,"activeCount":97},[],{"trials":2594,"activeCount":97},[],{"trials":2596,"activeCount":97},[],{"intervention":2590,"totalTrials":93,"cells":2598},{"EARLY_PHASE1":2599,"PHASE1":2601,"PHASE2":2603,"PHASE3":2609,"PHASE4":2611,"NA":2613},{"trials":2600,"activeCount":97},[],{"trials":2602,"activeCount":97},[],{"trials":2604,"activeCount":97},[2605],{"nctId":2580,"briefTitle":2581,"status":290,"phases":2606,"primaryCompletion":2583,"completion":2584,"start":2585,"enrollment":8,"conditions":2607,"interventions":2608},[87],[2587,2588],[2571,2590],{"trials":2610,"activeCount":97},[],{"trials":2612,"activeCount":97},[],{"trials":2614,"activeCount":97},[],{"intervention":2616,"totalTrials":93,"cells":2617},"Azithromycin Dihydrate",{"EARLY_PHASE1":2618,"PHASE1":2620,"PHASE2":2630,"PHASE3":2632,"PHASE4":2634,"NA":2636},{"trials":2619,"activeCount":97},[],{"trials":2621,"activeCount":97},[2622],{"nctId":2623,"briefTitle":2624,"status":397,"phases":2625,"primaryCompletion":1060,"completion":1060,"start":2626,"enrollment":174,"conditions":2627,"interventions":2629},"NCT05437783","Influence of Ethnicity and ABCB1 Gene Polymorphism on the Pharmacokinetics of Azithromycin in Healthy Bangladeshi Volunteers",[86],"2020-01-01",[2628],"Comparative Bioavailability Study",[2616],{"trials":2631,"activeCount":97},[],{"trials":2633,"activeCount":97},[],{"trials":2635,"activeCount":97},[],{"trials":2637,"activeCount":97},[],{"intervention":2639,"totalTrials":93,"cells":2640},"Carbetocin",{"EARLY_PHASE1":2641,"PHASE1":2653,"PHASE2":2655,"PHASE3":2657,"PHASE4":2659,"NA":2661},{"trials":2642,"activeCount":97},[2643],{"nctId":2644,"briefTitle":2645,"status":397,"phases":2646,"primaryCompletion":2647,"completion":2648,"start":2649,"enrollment":155,"conditions":2650,"interventions":2652},"NCT02396303","Carbetocin Versus Oxytocin in Caesarean Section for the Control of Postpartum Haemorrhage",[85],"2015-10","2015-11","2015-06",[2651],"Postpartum Haemorrhage",[2639],{"trials":2654,"activeCount":97},[],{"trials":2656,"activeCount":97},[],{"trials":2658,"activeCount":97},[],{"trials":2660,"activeCount":97},[],{"trials":2662,"activeCount":97},[],{"intervention":2664,"totalTrials":21,"cells":2665},"Cholecalciferol",{"EARLY_PHASE1":2666,"PHASE1":2668,"PHASE2":2680,"PHASE3":2702,"PHASE4":2704,"NA":2706},{"trials":2667,"activeCount":97},[],{"trials":2669,"activeCount":97},[2670],{"nctId":2671,"briefTitle":2672,"status":290,"phases":2673,"primaryCompletion":2674,"completion":2674,"start":2675,"enrollment":2676,"conditions":2677,"interventions":2679},"NCT03781895","Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients",[86],"2018-02-01","2017-03-01",48,[2678],"Stable COPD Patients",[2664],{"trials":2681,"activeCount":97},[2682,2692],{"nctId":2683,"briefTitle":2684,"status":290,"phases":2685,"primaryCompletion":2686,"completion":2687,"start":2688,"enrollment":278,"conditions":2689,"interventions":2691},"NCT03880734","This Study Include Asthma Chronic Obstructive Pulmonary Disease (COPD) Overlap Patients.Patients Were Vitamin D Deficient.Age Range 40-70 Years, Smokers.Patients Were Advised to Take Either Placebo or Vitamin D3.Lung Functions and Exercise Tolerance Were Assessed at Baseline and at 26th Weeks.",[87],"2018-11-01","2019-02-20","2018-03-01",[2690],"Asthma-COPD Overlap Syndrome",[2664],{"nctId":2693,"briefTitle":2694,"status":397,"phases":2695,"primaryCompletion":2696,"completion":2696,"start":2697,"enrollment":1062,"conditions":2698,"interventions":2700},"NCT04011930","This Study Include Chronic Obstructive Pulmonary Disease(COPD) Patients . Patients Were Vitamin D Deficient Age Range 40 to 80 Years, Smokers Patients Were Advised to Take Either Placebo or Vitamin D3 . Antioxidant Enzymes Were Assessed at Baseline and at 26th Weeks.",[87],"2020-02-28","2019-03-01",[2699],"Chronic Obstructive Pulmonary Disease",[2701],"cholecalciferol",{"trials":2703,"activeCount":97},[],{"trials":2705,"activeCount":97},[],{"trials":2707,"activeCount":97},[2708],{"nctId":2709,"briefTitle":2710,"status":290,"phases":2711,"primaryCompletion":2712,"completion":2713,"start":869,"enrollment":2714,"conditions":2715,"interventions":2717},"NCT03504280","Changes in Serum Vitamin D Level After Different Loading Doses of Cholecalciferol",[90],"2017-08","2017-10",105,[2716],"Hypovitaminosis D",[2664],{"intervention":2719,"totalTrials":266,"cells":2720},"Salicylic Acid",{"EARLY_PHASE1":2721,"PHASE1":2723,"PHASE2":2725,"PHASE3":2731,"PHASE4":2733,"NA":2735},{"trials":2722,"activeCount":97},[],{"trials":2724,"activeCount":97},[],{"trials":2726,"activeCount":97},[2727],{"nctId":2403,"briefTitle":2404,"status":290,"phases":2728,"primaryCompletion":2406,"completion":2406,"start":1638,"enrollment":11,"conditions":2729,"interventions":2730},[87],[14],[2394,2409],{"trials":2732,"activeCount":97},[],{"trials":2734,"activeCount":97},[],{"trials":2736,"activeCount":97},[2737],{"nctId":2738,"briefTitle":2739,"status":290,"phases":2740,"primaryCompletion":2741,"completion":2742,"start":2743,"enrollment":1613,"conditions":2744,"interventions":2745},"NCT01731756","Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis",[90],"2013-12","2014-03","2013-01",[20],[2719],{"intervention":2747,"totalTrials":266,"cells":2748},"Levocarnitine",{"EARLY_PHASE1":2749,"PHASE1":2751,"PHASE2":2753,"PHASE3":2765,"PHASE4":2767,"NA":2769},{"trials":2750,"activeCount":97},[],{"trials":2752,"activeCount":97},[],{"trials":2754,"activeCount":97},[2755],{"nctId":2756,"briefTitle":2757,"status":397,"phases":2758,"primaryCompletion":2759,"completion":2696,"start":2760,"enrollment":2761,"conditions":2762,"interventions":2764},"NCT04145245","A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement",[87],"2019-12-30","2018-04-17",104,[2763],"Patient Compliance",[2747],{"trials":2766,"activeCount":97},[],{"trials":2768,"activeCount":97},[],{"trials":2770,"activeCount":97},[2771],{"nctId":2772,"briefTitle":2773,"status":397,"phases":2774,"primaryCompletion":613,"completion":2775,"start":2776,"enrollment":518,"conditions":2777,"interventions":2778},"NCT03372772","Effect of Levocarnitine Supplementation for the Management of Fatigue in Levothyroxine-Treated Hypothyroid Patients",[90],"2018-02-28","2017-03-16",[2763],[2747],{"intervention":2780,"totalTrials":93,"cells":2781},"Nigella sativa seeds extract containing ointment intervention",{"EARLY_PHASE1":2782,"PHASE1":2784,"PHASE2":2786,"PHASE3":2788,"PHASE4":2790,"NA":2792},{"trials":2783,"activeCount":97},[],{"trials":2785,"activeCount":97},[],{"trials":2787,"activeCount":97},[],{"trials":2789,"activeCount":97},[],{"trials":2791,"activeCount":97},[],{"trials":2793,"activeCount":97},[2794],{"nctId":2795,"briefTitle":2796,"status":397,"phases":2797,"primaryCompletion":2798,"completion":2799,"start":2800,"enrollment":294,"conditions":2801,"interventions":2802},"NCT04686461","Effect of Thymoquinone Extracted From Nigella Sativa in the Treatment of Arsenical Keratosis",[90],"2021-01-20","2021-02-20","2019-10-20",[17],[2780],{"intervention":2804,"totalTrials":93,"cells":2805},"Vitamin C, Vitamin E",{"EARLY_PHASE1":2806,"PHASE1":2808,"PHASE2":2810,"PHASE3":2812,"PHASE4":2814,"NA":2816},{"trials":2807,"activeCount":97},[],{"trials":2809,"activeCount":97},[],{"trials":2811,"activeCount":97},[],{"trials":2813,"activeCount":97},[],{"trials":2815,"activeCount":97},[],{"trials":2817,"activeCount":97},[2818],{"nctId":2819,"briefTitle":2820,"status":397,"phases":2821,"primaryCompletion":1858,"completion":2822,"start":2823,"enrollment":110,"conditions":2824,"interventions":2826},"NCT04463459","Effect of Vitamin C and E in Breast Cancer Patients Undergoing Chemotherapy",[90],"2020-09-15","2019-10-10",[2825],"Breast Cancer",[2804],{"intervention":2828,"totalTrials":93,"cells":2829},"SSRI with Zinc Sulfate",{"EARLY_PHASE1":2830,"PHASE1":2832,"PHASE2":2834,"PHASE3":2836,"PHASE4":2838,"NA":2840},{"trials":2831,"activeCount":97},[],{"trials":2833,"activeCount":97},[],{"trials":2835,"activeCount":97},[],{"trials":2837,"activeCount":97},[],{"trials":2839,"activeCount":97},[],{"trials":2841,"activeCount":97},[2842],{"nctId":2843,"briefTitle":2844,"status":290,"phases":2845,"primaryCompletion":2846,"completion":2847,"start":2848,"enrollment":155,"conditions":2849,"interventions":2850},"NCT04482296","Effect of Zinc Supplementation on Depression in SSRI-treated Major Depressive Disorder Patients",[90],"2020-07-15","2020-08-20","2019-09-15",[28],[2828],{"intervention":2852,"totalTrials":93,"cells":2853},"N-acetylcysteine tablet 600mg",{"EARLY_PHASE1":2854,"PHASE1":2856,"PHASE2":2858,"PHASE3":2860,"PHASE4":2862,"NA":2864},{"trials":2855,"activeCount":97},[],{"trials":2857,"activeCount":97},[],{"trials":2859,"activeCount":97},[],{"trials":2861,"activeCount":97},[],{"trials":2863,"activeCount":97},[],{"trials":2865,"activeCount":97},[2866],{"nctId":2867,"briefTitle":2868,"status":397,"phases":2869,"primaryCompletion":2870,"completion":2870,"start":2871,"enrollment":459,"conditions":2872,"interventions":2873},"NCT04904952","Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients",[90],"2022-01-10","2020-03-13",[32],[2852],{"intervention":2875,"totalTrials":93,"cells":2876},"Vitamin B 6 with Magnesium",{"EARLY_PHASE1":2877,"PHASE1":2879,"PHASE2":2881,"PHASE3":2883,"PHASE4":2885,"NA":2887},{"trials":2878,"activeCount":97},[],{"trials":2880,"activeCount":97},[],{"trials":2882,"activeCount":97},[],{"trials":2884,"activeCount":97},[],{"trials":2886,"activeCount":97},[],{"trials":2888,"activeCount":97},[2889],{"nctId":2890,"briefTitle":2891,"status":290,"phases":2892,"primaryCompletion":2893,"completion":2893,"start":2894,"enrollment":2094,"conditions":2895,"interventions":2897},"NCT04509401","Effects of High Dose of Vitamin B6 With Magnesium in Children With Autism Spectrum Disorder",[90],"2020-11-15","2020-01-11",[2896],"ASD",[2875],{"intervention":2899,"totalTrials":93,"cells":2900},"Paracetamol 500 mg tablet at morning",{"EARLY_PHASE1":2901,"PHASE1":2903,"PHASE2":2905,"PHASE3":2907,"PHASE4":2909,"NA":2911},{"trials":2902,"activeCount":97},[],{"trials":2904,"activeCount":97},[],{"trials":2906,"activeCount":97},[],{"trials":2908,"activeCount":97},[],{"trials":2910,"activeCount":97},[],{"trials":2912,"activeCount":97},[2913],{"nctId":2914,"briefTitle":2915,"status":290,"phases":2916,"primaryCompletion":2917,"completion":2917,"start":2918,"enrollment":2919,"conditions":2920,"interventions":2922},"NCT03122561","Estimation of Paracetamol in Urine to Assess the Diurnal Variation",[90],"2018-01-30","2016-11-03",46,[2921],"Diurnal Variation of Paracetamol Excretion",[2899,2923,2924],"Paracetamol 500 mg tablet at midday","Paracetamol 500 mg tablet at night",{"intervention":2923,"totalTrials":93,"cells":2926},{"EARLY_PHASE1":2927,"PHASE1":2929,"PHASE2":2931,"PHASE3":2933,"PHASE4":2935,"NA":2937},{"trials":2928,"activeCount":97},[],{"trials":2930,"activeCount":97},[],{"trials":2932,"activeCount":97},[],{"trials":2934,"activeCount":97},[],{"trials":2936,"activeCount":97},[],{"trials":2938,"activeCount":97},[2939],{"nctId":2914,"briefTitle":2915,"status":290,"phases":2940,"primaryCompletion":2917,"completion":2917,"start":2918,"enrollment":2919,"conditions":2941,"interventions":2942},[90],[2921],[2899,2923,2924],{"intervention":2924,"totalTrials":93,"cells":2944},{"EARLY_PHASE1":2945,"PHASE1":2947,"PHASE2":2949,"PHASE3":2951,"PHASE4":2953,"NA":2955},{"trials":2946,"activeCount":97},[],{"trials":2948,"activeCount":97},[],{"trials":2950,"activeCount":97},[],{"trials":2952,"activeCount":97},[],{"trials":2954,"activeCount":97},[],{"trials":2956,"activeCount":97},[2957],{"nctId":2914,"briefTitle":2915,"status":290,"phases":2958,"primaryCompletion":2917,"completion":2917,"start":2918,"enrollment":2919,"conditions":2959,"interventions":2960},[90],[2921],[2899,2923,2924],{"intervention":2962,"totalTrials":93,"cells":2963},"Group A- 0.15% Guava leaf extract mouthwash group",{"EARLY_PHASE1":2964,"PHASE1":2966,"PHASE2":2968,"PHASE3":2970,"PHASE4":2972,"NA":2974},{"trials":2965,"activeCount":97},[],{"trials":2967,"activeCount":97},[],{"trials":2969,"activeCount":97},[],{"trials":2971,"activeCount":97},[],{"trials":2973,"activeCount":97},[],{"trials":2975,"activeCount":97},[2976],{"nctId":2977,"briefTitle":2978,"status":290,"phases":2979,"primaryCompletion":52,"completion":52,"start":2980,"enrollment":543,"conditions":2981,"interventions":2983},"NCT07059572","Comparative Evaluation of Guava Leaf Extract and Chlorhexidine Mouthwash in Patients With Chronic Gingivitis",[90],"2025-05-27",[2982],"Chronic Gingivitis, Plaque Induced",[2962,2984],"Group B- 0.2% Chlorhexidine mouthwash",{"intervention":2984,"totalTrials":93,"cells":2986},{"EARLY_PHASE1":2987,"PHASE1":2989,"PHASE2":2991,"PHASE3":2993,"PHASE4":2995,"NA":2997},{"trials":2988,"activeCount":97},[],{"trials":2990,"activeCount":97},[],{"trials":2992,"activeCount":97},[],{"trials":2994,"activeCount":97},[],{"trials":2996,"activeCount":97},[],{"trials":2998,"activeCount":97},[2999],{"nctId":2977,"briefTitle":2978,"status":290,"phases":3000,"primaryCompletion":52,"completion":52,"start":2980,"enrollment":543,"conditions":3001,"interventions":3002},[90],[2982],[2962,2984],{"intervention":3004,"totalTrials":93,"cells":3005},"SmartAMR",{"EARLY_PHASE1":3006,"PHASE1":3008,"PHASE2":3010,"PHASE3":3012,"PHASE4":3014,"NA":3016},{"trials":3007,"activeCount":97},[],{"trials":3009,"activeCount":97},[],{"trials":3011,"activeCount":97},[],{"trials":3013,"activeCount":97},[],{"trials":3015,"activeCount":97},[],{"trials":3017,"activeCount":97},[3018],{"nctId":3019,"briefTitle":3020,"status":290,"phases":3021,"primaryCompletion":439,"completion":3022,"start":3023,"enrollment":3024,"conditions":3025,"interventions":3029},"NCT06313619","Decreasing Irrational Antimicrobial Use in Bangladesh: A Digital Intervention Program",[90],"2024-10-31","2023-10-23",27,[3026,3027,3028],"Resistance Bacterial","Increased Drug Resistance","Drug Resistance, Microbial",[3004],{"intervention":3031,"totalTrials":93,"cells":3032},"Azadirachta indica leaves extract containing ointment intervention.",{"EARLY_PHASE1":3033,"PHASE1":3035,"PHASE2":3037,"PHASE3":3039,"PHASE4":3041,"NA":3043},{"trials":3034,"activeCount":97},[],{"trials":3036,"activeCount":97},[],{"trials":3038,"activeCount":97},[],{"trials":3040,"activeCount":97},[],{"trials":3042,"activeCount":97},[],{"trials":3044,"activeCount":97},[3045],{"nctId":3046,"briefTitle":3047,"status":397,"phases":3048,"primaryCompletion":2798,"completion":2799,"start":2800,"enrollment":3049,"conditions":3050,"interventions":3051},"NCT04686474","Effect of the Compound Extracted From Azadirachta Indica Leaves in the Treatment of Arsenical Keratosis",[90],35,[17],[3031],{"intervention":3053,"totalTrials":93,"cells":3054},"Pyridoxine",{"EARLY_PHASE1":3055,"PHASE1":3057,"PHASE2":3059,"PHASE3":3061,"PHASE4":3063,"NA":3065},{"trials":3056,"activeCount":97},[],{"trials":3058,"activeCount":97},[],{"trials":3060,"activeCount":97},[],{"trials":3062,"activeCount":97},[],{"trials":3064,"activeCount":97},[],{"trials":3066,"activeCount":97},[3067],{"nctId":3068,"briefTitle":3069,"status":397,"phases":3070,"primaryCompletion":3071,"completion":515,"start":3072,"enrollment":3073,"conditions":3074,"interventions":3075},"NCT06244121","Effect of Pyridoxine as Add-on Therapy in OCD Patients",[90],"2024-06-15","2023-06-03",76,[32],[3053]]